{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T12:17:03Z","timestamp":1795004223806,"version":"4.9.1"},"reference-count":314,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,5,19]],"date-time":"2016-05-19T00:00:00Z","timestamp":1463616000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1038\/nrcardio.2016.76","type":"journal-article","created":{"date-parts":[[2016,5,20]],"date-time":"2016-05-20T20:21:29Z","timestamp":1463775689000},"page":"451-470","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":286,"title":["Vein graft failure: from pathophysiology to clinical outcomes"],"prefix":"10.1038","volume":"13","author":[{"given":"Margreet R.","family":"de Vries","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin H.","family":"Simons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Wouter","family":"Jukema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul H. A.","family":"Quax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,19]]},"reference":[{"key":"BFnrcardio201676_CR1","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1056\/NEJMoa1110717","volume":"366","author":"WS Weintraub","year":"2012","unstructured":"Weintraub, W. S. et al. Comparative effectiveness of revascularization strategies. N. Engl. J. Med. 366, 1467\u20131476 (2012).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201676_CR2","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1001\/jama.2013.281718","volume":"310","author":"S Deb","year":"2013","unstructured":"Deb, S. et al. Coronary artery bypass graft surgery versus percutaneous interventions in coronary revascularization: a systematic review. JAMA 310, 2086\u20132095 (2013).","journal-title":"JAMA"},{"key":"BFnrcardio201676_CR3","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jvs.2009.07.102","volume":"51","author":"CD Owens","year":"2010","unstructured":"Owens, C. D. Adaptive changes in autogenous vein grafts for arterial reconstruction: clinical implications. J. Vasc. Surg. 51, 736\u2013746 (2010).","journal-title":"J. Vasc. Surg."},{"key":"BFnrcardio201676_CR4","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","volume":"35","author":"S Windecker","year":"2014","unstructured":"Windecker, S. et al. 2014 ESC\/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur. Heart J. 35, 2541\u20132619 (2014).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio201676_CR5","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/j.jacc.2004.08.064","volume":"44","author":"S Goldman","year":"2004","unstructured":"Goldman, S. et al. Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study. J. Am. Coll. Cardiol. 44, 2149\u20132156 (2004).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201676_CR6","unstructured":"Carrel, A. & Guthrie, C. C. Uniterminal and biterminal venous transplantations. Surg. Gynecol. Obstet. 266\u2013286 (1906)."},{"key":"BFnrcardio201676_CR7","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/0002-8703(87)90780-0","volume":"114","author":"AE Walts","year":"1987","unstructured":"Walts, A. E., Fishbein, M. C. & Matloff, J. M. Thrombosed, ruptured atheromatous plaques in saphenous vein coronary artery bypass grafts: ten years' experience. Am. Heart J. 114, 718\u2013723 (1987).","journal-title":"Am. Heart J."},{"key":"BFnrcardio201676_CR8","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1161\/01.CIR.97.9.916","volume":"97","author":"JG Motwani","year":"1998","unstructured":"Motwani, J. G. & Topol, E. J. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation 97, 916\u2013931 (1998).","journal-title":"Circulation"},{"key":"BFnrcardio201676_CR9","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jtcvs.2013.10.011","volume":"148","author":"B Yanagawa","year":"2014","unstructured":"Yanagawa, B. et al. Clinical, biochemical, and genetic predictors of coronary artery bypass graft failure. J. Thorac. Cardiovasc. Surg. 148, 515\u2013520 (2014).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"BFnrcardio201676_CR10","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1517\/14740330903188413","volume":"8","author":"A Kulik","year":"2009","unstructured":"Kulik, A. & Ruel, M. Statins and coronary artery bypass graft surgery: preoperative and postoperative efficacy and safety. Expert. Opin. Drug Saf. 8, 559\u2013571 (2009).","journal-title":"Expert. Opin. Drug Saf."},{"key":"BFnrcardio201676_CR11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0967-2109(00)00088-0","volume":"9","author":"JT Christenson","year":"2001","unstructured":"Christenson, J. T. Preoperative lipid control with simvastatin reduces the risk for graft failure already 1 year after myocardial revascularization. Cardiovasc. Surg. 9, 33\u201343 (2001).","journal-title":"Cardiovasc. Surg."},{"key":"BFnrcardio201676_CR12","doi-asserted-by":"crossref","first-page":"1000154","DOI":"10.4172\/2324-8602.1000154","volume":"2","author":"JT Efird","year":"2013","unstructured":"Efird, J. T. et al. Implications of hemodialysis in patients undergoing coronary artery bypass grafting. Int. J. Cardiovasc. Res. 2, 1000154 (2013).","journal-title":"Int. J. Cardiovasc. Res."},{"key":"BFnrcardio201676_CR13","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jvs.2005.05.001","volume":"42","author":"MS Conte","year":"2005","unstructured":"Conte, M. S. et al. Risk factors, medical therapies and perioperative events in limb salvage surgery: observations from the PREVENT III multicenter trial. J. Vasc. Surg. 42, 456\u2013464 (2005).","journal-title":"J. Vasc. Surg."},{"key":"BFnrcardio201676_CR14","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1053\/j.semvascsurg.2009.10.003","volume":"22","author":"TS Monahan","year":"2009","unstructured":"Monahan, T. S. & Owens, C. D. Risk factors for lower-extremity vein graft failure. Semin. Vasc. Surg. 22, 216\u2013226 (2009).","journal-title":"Semin. Vasc. Surg."},{"key":"BFnrcardio201676_CR15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1053\/j.semvascsurg.2008.05.007","volume":"21","author":"CD Owens","year":"2008","unstructured":"Owens, C. D., Ho, K. J. & Conte, M. S. Risk factors for failure of lower-extremity revascularization procedures: are they different for bypass and percutaneous procedures? Semin. Vasc. Surg. 21, 143\u2013153 (2008).","journal-title":"Semin. Vasc. Surg."},{"key":"BFnrcardio201676_CR16","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jss.2007.03.062","volume":"142","author":"ZN Kon","year":"2007","unstructured":"Kon, Z. N. et al. The role of preexisting pathology in the development of neointimal hyperplasia in coronary artery bypass grafts. J. Surg. Res. 142, 351\u2013356 (2007).","journal-title":"J. Surg. Res."},{"key":"BFnrcardio201676_CR17","doi-asserted-by":"crossref","first-page":"e70628","DOI":"10.1371\/journal.pone.0070628","volume":"8","author":"B Perek","year":"2013","unstructured":"Perek, B. et al. Predictive factors of late venous aortocoronary graft failure: ultrastructural studies. PLoS ONE 8, e70628 (2013).","journal-title":"PLoS ONE"},{"key":"BFnrcardio201676_CR18","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1161\/CIRCULATIONAHA.113.008193","volume":"130","author":"CN Hess","year":"2014","unstructured":"Hess, C. N. et al. Saphenous vein graft failure after coronary artery bypass surgery: insights from PREVENT IV. Circulation 130, 1445\u20131451 (2014).","journal-title":"Circulation"},{"key":"BFnrcardio201676_CR19","first-page":"e652","volume":"124","author":"LD Hillis","year":"2011","unstructured":"Hillis, L. D. et al. 2011 ACCF\/AHA Guideline for Coronary Artery Bypass Graft Surgery: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Circulation 124, e652\u2013e735 (2011).","journal-title":"Circulation"},{"key":"BFnrcardio201676_CR20","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1093\/eurheartj\/ehr211","volume":"32","author":"M Tendera","year":"2011","unstructured":"Tendera, M. et al. ESC guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur. Heart J. 32, 2851\u20132906 (2011).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio201676_CR21","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1161\/CIR.0b013e31828b82aa","volume":"127","author":"JL Anderson","year":"2013","unstructured":"Anderson, J. L. et al. Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF\/AHA guideline recommendations): a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Circulation 127, 1425\u20131443 (2013).","journal-title":"Circulation"},{"key":"BFnrcardio201676_CR22","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/gt.2012.29","volume":"19","author":"S Wan","year":"2012","unstructured":"Wan, S., George, S. J., Berry, C. & Baker, A. H. Vein graft failure: current clinical practice and potential for gene therapeutics. Gene Ther. 19, 630\u2013636 (2012).","journal-title":"Gene Ther."},{"key":"BFnrcardio201676_CR23","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1161\/01.RES.0000036901.58329.D7","volume":"91","author":"JH Lardenoye","year":"2002","unstructured":"Lardenoye, J. H. et al. Accelerated atherosclerosis and calcification in vein grafts: a study in APOE*3 Leiden transgenic mice. Circ. Res. 91, 577\u2013584 (2002).","journal-title":"Circ. Res."},{"key":"BFnrcardio201676_CR24","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.jvs.2006.06.005","volume":"44","author":"CD Owens","year":"2006","unstructured":"Owens, C. D. et al. Early biomechanical changes in lower extremity vein grafts \u2014 distinct temporal phases of remodeling and wall stiffness. J. Vasc. Surg. 44, 740\u2013746 (2006).","journal-title":"J. Vasc. Surg."},{"key":"BFnrcardio201676_CR25","doi-asserted-by":"crossref","first-page":"e47134","DOI":"10.1371\/journal.pone.0047134","volume":"7","author":"MR de Vries","year":"2012","unstructured":"de Vries, M. R. et al. Plaque rupture complications in murine atherosclerotic vein grafts can be prevented by TIMP-1 overexpression. PLoS ONE 7, e47134 (2012).","journal-title":"PLoS ONE"},{"key":"BFnrcardio201676_CR26","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nrcardio.2015.164","volume":"13","author":"K Yahagi","year":"2016","unstructured":"Yahagi, K. et al. Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis. Nat. Rev. Cardiol. 13, 79\u201398 (2016).","journal-title":"Nat. Rev. Cardiol."},{"key":"BFnrcardio201676_CR27","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0002-9440(10)63099-4","volume":"164","author":"S Kwei","year":"2004","unstructured":"Kwei, S. et al. Early adaptive responses of the vascular wall during venous arterialization in mice. Am. J. Pathol. 164, 81\u201389 (2004).","journal-title":"Am. J. Pathol."},{"key":"BFnrcardio201676_CR28","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.coph.2012.01.005","volume":"12","author":"H Weaver","year":"2012","unstructured":"Weaver, H., Shukla, N., Ellinsworth, D. & Jeremy, J. Y. Oxidative stress and vein graft failure: a focus on NADH oxidase, nitric oxide and eicosanoids. Curr. Opin. Pharmacol. 12, 160\u2013165 (2012).","journal-title":"Curr. Opin. Pharmacol."},{"key":"BFnrcardio201676_CR29","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jvs.2013.06.004","volume":"60","author":"MJ Osgood","year":"2014","unstructured":"Osgood, M. J. et al. Surgical vein graft preparation promotes cellular dysfunction, oxidative stress, and intimal hyperplasia in human saphenous vein. J. Vasc. Surg. 60, 202\u2013211 (2014).","journal-title":"J. Vasc. Surg."},{"key":"BFnrcardio201676_CR30","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1067\/mva.2001.112230","volume":"33","author":"A Westerband","year":"2001","unstructured":"Westerband, A. et al. Vein adaptation to arterialization in an experimental model. J. Vasc. Surg. 33, 561\u2013569 (2001).","journal-title":"J. Vasc. Surg."},{"key":"BFnrcardio201676_CR31","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1365-2613.2009.00648.x","volume":"90","author":"TF Borin","year":"2009","unstructured":"Borin, T. F. et al. Apoptosis, cell proliferation and modulation of cyclin-dependent kinase inhibitor p21cip1 in vascular remodelling during vein arterialization in the rat. Int. J. Exp. Pathol. 90, 328\u2013337 (2009).","journal-title":"Int. J. Exp. Pathol."},{"key":"BFnrcardio201676_CR32","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1161\/01.CIR.0000013775.02396.93","volume":"105","author":"A Ehsan","year":"2002","unstructured":"Ehsan, A. et al. Endothelial healing in vein grafts: proliferative burst unimpaired by genetic therapy of neointimal disease. Circulation 105, 1686\u20131692 (2002).","journal-title":"Circulation"},{"key":"BFnrcardio201676_CR33","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00595-008-3912-6","volume":"39","author":"M Sugimoto","year":"2009","unstructured":"Sugimoto, M., Yamanouchi, D. & Komori, K. Therapeutic approach against intimal hyperplasia of vein grafts through endothelial nitric oxide synthase\/nitric oxide (eNOS\/NO) and the Rho\/Rho-kinase pathway. Surg. Today 39, 459\u2013465 (2009).","journal-title":"Surg. Today"},{"key":"BFnrcardio201676_CR34","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1161\/01.CIR.103.19.2408","volume":"103","author":"Y Shi","year":"2001","unstructured":"Shi, Y. et al. Oxidative stress and lipid retention in vascular grafts: comparison between venous and arterial conduits. Circulation 103, 2408\u20132413 (2001).","journal-title":"Circulation"},{"key":"BFnrcardio201676_CR35","doi-asserted-by":"crossref","first-page":"S249","DOI":"10.1067\/msy.2002.119797","volume":"131","author":"K Komori","year":"2002","unstructured":"Komori, K., Inoguchi, H., Kume, M., Shoji, T. & Furuyama, T. Differences in endothelial function and morphologic modulation between canine autogenous venous and arterial grafts: endothelium and intimal thickening. Surgery 131, S249\u2013S255 (2002).","journal-title":"Surgery"},{"key":"BFnrcardio201676_CR36","doi-asserted-by":"crossref","first-page":"e98904","DOI":"10.1371\/journal.pone.0098904","volume":"9","author":"CN Tseng","year":"2014","unstructured":"Tseng, C. N. et al. Contribution of endothelial injury and inflammation in early phase to vein graft failure: the causal factors impact on the development of intimal hyperplasia in murine models. PLoS ONE 9, e98904 (2014).","journal-title":"PLoS ONE"},{"key":"BFnrcardio201676_CR37","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/bjs.1800780310","volume":"78","author":"T Yukizane","year":"1991","unstructured":"Yukizane, T., Okadome, K., Eguchi, H., Muto, Y. & Sugimachi, K. Isotopic study of the effects of platelets on development of intimal thickening in autologous vein grafts in dogs. Br. J. Surg. 78, 297\u2013302 (1991).","journal-title":"Br. J. Surg."},{"key":"BFnrcardio201676_CR38","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1182\/blood-2010-01-261206","volume":"116","author":"D Lievens","year":"2010","unstructured":"Lievens, D. et al. Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis. Blood 116, 4317\u20134327 (2010).","journal-title":"Blood"},{"key":"BFnrcardio201676_CR39","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1146\/annurev-pharmtox-010814-124438","volume":"55","author":"JP Depta","year":"2015","unstructured":"Depta, J. P. & Bhatt, D. L. New approaches to inhibiting platelets and coagulation. Annu. Rev. Pharmacol. Toxicol. 55, 373\u2013397 (2015).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"BFnrcardio201676_CR40","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.lfs.2012.03.024","volume":"91","author":"R Cerrato","year":"2012","unstructured":"Cerrato, R. et al. Endothelin-1 increases superoxide production in human coronary artery bypass grafts. Life Sci. 91, 723\u2013728 (2012).","journal-title":"Life Sci."},{"key":"BFnrcardio201676_CR41","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1161\/hc3801.095693","volume":"104","author":"NE West","year":"2001","unstructured":"West, N. E. et al. Nitric oxide synthase (nNOS) gene transfer modifies venous bypass graft remodeling: effects on vascular smooth muscle cell differentiation and superoxide production. Circulation 104, 1526\u20131532 (2001).","journal-title":"Circulation"},{"key":"BFnrcardio201676_CR42","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jvs.2007.03.044","volume":"46","author":"K Hattori","year":"2007","unstructured":"Hattori, K. et al. Celiprolol reduces the intimal thickening of autogenous vein grafts via an enhancement of nitric oxide function through an inhibition of superoxide production. J. Vasc. Surg. 46, 116\u2013123 (2007).","journal-title":"J. Vasc. Surg."},{"key":"BFnrcardio201676_CR43","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0002-9440(10)65675-1","volume":"153","author":"Y Zou","year":"1998","unstructured":"Zou, Y. et al. Mouse model of venous bypass graft arteriosclerosis. Am. J. Pathol. 153, 1301\u20131310 (1998).","journal-title":"Am. J. Pathol."},{"key":"BFnrcardio201676_CR44","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jvs.2009.06.022","volume":"50","author":"CD Owens","year":"2009","unstructured":"Owens, C. D., Wake, N., Conte, M. S., Gerhard-Herman, M. & Beckman, J. A. In vivo human lower extremity saphenous vein bypass grafts manifest flow mediated vasodilation. J. Vasc. Surg. 50, 1063\u20131070 (2009).","journal-title":"J. Vasc. Surg."},{"key":"BFnrcardio201676_CR45","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1172\/JCI19628","volume":"113","author":"Y Hu","year":"2004","unstructured":"Hu, Y. et al. Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice. J. Clin. Invest. 113, 1258\u20131265 (2004).","journal-title":"J. Clin. Invest."},{"key":"BFnrcardio201676_CR46","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jss.2005.01.025","volume":"126","author":"Y Diao","year":"2005","unstructured":"Diao, Y., Xue, J. & Segal, M. S. A novel mouse model of autologous venous graft intimal hyperplasia. J. Surg. Res. 126, 106\u2013113 (2005).","journal-title":"J. Surg. Res."},{"key":"BFnrcardio201676_CR47","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.tcm.2005.02.003","volume":"15","author":"E Torsney","year":"2005","unstructured":"Torsney, E., Hu, Y. & Xu, Q. Adventitial progenitor cells contribute to arteriosclerosis. Trends Cardiovasc. Med. 15, 64\u201368 (2005).","journal-title":"Trends Cardiovasc. Med."},{"key":"BFnrcardio201676_CR48","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1161\/ATVBAHA.110.207076","volume":"30","author":"MA Brown","year":"2010","unstructured":"Brown, M. A. et al. Human umbilical cord blood-derived endothelial cells reendothelialize vein grafts and prevent thrombosis. Arterioscler. Thromb. Vasc. Biol. 30, 2150\u20132155 (2010).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrcardio201676_CR49","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/path.2660","volume":"220","author":"AR Watson","year":"2010","unstructured":"Watson, A. R. et al. Deficiency of bone marrow \u03b23-integrin enhances non-functional neovascularization. J. Pathol. 220, 435\u2013445 (2010).","journal-title":"J. Pathol."},{"key":"BFnrcardio201676_CR50","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1161\/ATVBAHA.114.305089","volume":"35","author":"M Liang","year":"2015","unstructured":"Liang, M. et al. Impaired integrin \u03b23 delays endothelial cell regeneration and contributes to arteriovenous graft failure in mice. Arterioscler. Thromb. Vasc. Biol. 35, 607\u2013615 (2015).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrcardio201676_CR51","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/ATVBAHA.113.302568","volume":"34","author":"MM Wong","year":"2014","unstructured":"Wong, M. M. et al. Macrophages control vascular stem\/progenitor cell plasticity through tumor necrosis factor-\u03b1-mediated nuclear factor-\u03baB activation. Arterioscler. Thromb. Vasc. Biol. 34, 635\u2013643 (2014).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrcardio201676_CR52","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1161\/01.RES.0000201957.09227.6d","volume":"98","author":"U Mayr","year":"2006","unstructured":"Mayr, U. et al. Accelerated arteriosclerosis of vein grafts in inducible NO synthase\u2212\/\u2212 mice is related to decreased endothelial progenitor cell repair. Circ. Res. 98, 412\u2013420 (2006).","journal-title":"Circ. Res."},{"key":"BFnrcardio201676_CR53","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1067\/mva.2000.105676","volume":"31","author":"TR Johnson","year":"2000","unstructured":"Johnson, T. R., Tomaszewski, J. E. & Carpenter, J. P. Cellular repopulation of human vein allograft bypass grafts. J. Vasc. Surg. 31, 994\u20131002 (2000).","journal-title":"J. Vasc. Surg."},{"key":"BFnrcardio201676_CR54","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1001\/archsurg.1964.01320010115011","volume":"89","author":"DE Szilagyi","year":"1964","unstructured":"Szilagyi, D. E., Smith, R. F. & Elliott, J. P. Venous autografts in femoropolpitieal arterioplasty. Obervations in the treatment of occlusive disease. Arch. Surg. 89, 113\u2013125 (1964).","journal-title":"Arch. Surg."},{"key":"BFnrcardio201676_CR55","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/1358863X07083432","volume":"13","author":"CD Owens","year":"2008","unstructured":"Owens, C. D., Ho, K. J. & Conte, M. S. Lower extremity vein graft failure: a translational approach. Vasc. Med. 13, 63\u201374 (2008).","journal-title":"Vasc. Med."},{"key":"BFnrcardio201676_CR56","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.vph.2012.07.008","volume":"58","author":"MR Dashwood","year":"2013","unstructured":"Dashwood, M. R. & Tsui, J. C. 'No-touch' saphenous vein harvesting improves graft performance in patients undergoing coronary artery bypass surgery: a journey from bedside to bench. Vascul. Pharmacol. 58, 240\u2013250 (2013).","journal-title":"Vascul. Pharmacol."},{"key":"BFnrcardio201676_CR57","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1152\/physrev.00047.2009","volume":"91","author":"JJ Chiu","year":"2011","unstructured":"Chiu, J. J. & Chien, S. Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives. Physiol. Rev. 91, 327\u2013387 (2011).","journal-title":"Physiol. Rev."},{"key":"BFnrcardio201676_CR58","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.jvs.2012.09.041","volume":"57","author":"X Berard","year":"2013","unstructured":"Berard, X. et al. Role of hemodynamic forces in the ex vivo arterialization of human saphenous veins. J. Vasc. Surg. 57, 1371\u20131382 (2013).","journal-title":"J. Vasc. Surg."},{"key":"BFnrcardio201676_CR59","first-page":"393","volume":"105","author":"PB Dobrin","year":"1989","unstructured":"Dobrin, P. B., Littooy, F. N. & Endean, E. D. Mechanical factors predisposing to intimal hyperplasia and medial thickening in autogenous vein grafts. Surgery 105, 393\u2013400 (1989).","journal-title":"Surgery"},{"key":"BFnrcardio201676_CR60","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1067\/mva.2001.114819","volume":"34","author":"SL Meyerson","year":"2001","unstructured":"Meyerson, S. L. et al. The effects of extremely low shear stress on cellular proliferation and neointimal thickening in the failing bypass graft. J. Vasc. Surg. 34, 90\u201397 (2001).","journal-title":"J. Vasc. Surg."},{"key":"BFnrcardio201676_CR61","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/j.jvs.2011.11.057","volume":"55","author":"P Zilla","year":"2012","unstructured":"Zilla, P. et al. Remodeling leads to distinctly more intimal hyperplasia in coronary than in infrainguinal vein grafts. J. Vasc. Surg. 55, 1734\u20131741 (2012).","journal-title":"J. Vasc. Surg."},{"key":"BFnrcardio201676_CR62","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1476-7120-2-8","volume":"2","author":"GJ Murphy","year":"2004","unstructured":"Murphy, G. J. & Angelini, G. D. Insights into the pathogenesis of vein graft disease: lessons from intravascular ultrasound. Cardiovasc. Ultrasound 2, 8 (2004).","journal-title":"Cardiovasc. Ultrasound"},{"key":"BFnrcardio201676_CR63","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.jacc.2008.12.048","volume":"53","author":"YJ Hong","year":"2009","unstructured":"Hong, Y. J. et al. Disease progression in nonintervened saphenous vein graft segments a serial intravascular ultrasound analysis. J. Am. Coll. Cardiol. 53, 1257\u20131264 (2009).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201676_CR64","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.atherosclerosis.2007.06.029","volume":"196","author":"AP Wong","year":"2008","unstructured":"Wong, A. P. et al. Expansive remodeling in venous bypass grafts: novel implications for vein graft disease. Atherosclerosis 196, 580\u2013589 (2008).","journal-title":"Atherosclerosis"},{"key":"BFnrcardio201676_CR65","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1161\/01.ATV.20.8.1889","volume":"20","author":"K Mavromatis","year":"2000","unstructured":"Mavromatis, K. et al. Early effects of arterial hemodynamic conditions on human saphenous veins perfused ex vivo. Arterioscler. Thromb. Vasc. Biol. 20, 1889\u20131895 (2000).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrcardio201676_CR66","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/bjs.1800540216","volume":"54","author":"M McCabe","year":"1967","unstructured":"McCabe, M., Cunningham, G. J., Wyatt, A. P., Rothnie, N. G. & Taylor, G. W. A histological and histochemical examination of autogenous vein grafts. Br. J. Surg. 54, 147\u2013155 (1967).","journal-title":"Br. J. Surg."},{"key":"BFnrcardio201676_CR67","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1056\/NEJM198705283162204","volume":"316","author":"S Glagov","year":"1987","unstructured":"Glagov, S., Weisenberg, E., Zarins, C. K., Stankunavicius, R. & Kolettis, G. J. Compensatory enlargement of human atherosclerotic coronary arteries. N. Engl. J. Med. 316, 1371\u20131375 (1987).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201676_CR68","first-page":"I435","volume":"114","author":"GT Lau","year":"2006","unstructured":"Lau, G. T. et al. Lumen loss in the first year in saphenous vein grafts is predominantly a result of negative remodeling of the whole vessel rather than a result of changes in wall thickness. Circulation 114, I435\u2013I440 (2006).","journal-title":"Circulation"},{"key":"BFnrcardio201676_CR69","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jvs.2012.06.098","volume":"57","author":"WJ Gasper","year":"2013","unstructured":"Gasper, W. J. et al. Thirty-day vein remodeling is predictive of midterm graft patency after lower extremity bypass. J. Vasc. Surg. 57, 9\u201318 (2013).","journal-title":"J. Vasc. Surg."},{"key":"BFnrcardio201676_CR70","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1161\/01.CIR.94.7.1741","volume":"94","author":"MB Izzat","year":"1996","unstructured":"Izzat, M. B. et al. Influence of external stent size on early medial and neointimal thickening in a pig model of saphenous vein bypass grafting. Circulation 94, 1741\u20131745 (1996).","journal-title":"Circulation"},{"key":"BFnrcardio201676_CR71","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1067\/mtc.2002.127004","volume":"124","author":"GD Angelini","year":"2002","unstructured":"Angelini, G. D., Lloyd, C., Bush, R., Johnson, J. & Newby, A. C. An external, oversized, porous polyester stent reduces vein graft neointima formation, cholesterol concentration, and vascular cell adhesion molecule 1 expression in cholesterol-fed pigs. J. Thorac. Cardiovasc. Surg. 124, 950\u2013956 (2002).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"BFnrcardio201676_CR72","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1161\/01.ATV.0000030339.79524.6E","volume":"22","author":"JH Lardenoye","year":"2002","unstructured":"Lardenoye, J. H. et al. Inhibition of accelerated atherosclerosis in vein grafts by placement of external stent in apoE*3-Leiden transgenic mice. Arterioscler. Thromb. Vasc. Biol. 22, 1433\u20131438 (2002).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrcardio201676_CR73","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/ejcts\/ezs670","volume":"44","author":"L Moodley","year":"2013","unstructured":"Moodley, L. et al. Protective constriction of coronary vein grafts with knitted nitinol. Eur. J. Cardiothorac. Surg. 44, 64\u201371 (2013).","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"BFnrcardio201676_CR74","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1016\/j.biomaterials.2013.12.041","volume":"35","author":"A Longchamp","year":"2014","unstructured":"Longchamp, A. et al. The use of external mesh reinforcement to reduce intimal hyperplasia and preserve the structure of human saphenous veins. Biomaterials 35, 2588\u20132599 (2014).","journal-title":"Biomaterials"},{"key":"BFnrcardio201676_CR75","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1159\/000054091","volume":"37","author":"M Kalra","year":"2000","unstructured":"Kalra, M. & Miller, V. M. Early remodeling of saphenous vein grafts: proliferation, migration and apoptosis of adventitial and medial cells occur simultaneously with changes in graft diameter and blood flow. J. Vasc. Res. 37, 576\u2013584 (2000).","journal-title":"J. Vasc. Res."},{"key":"BFnrcardio201676_CR76","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1440-1711.2005.01407.x","volume":"84","author":"AK Mitra","year":"2006","unstructured":"Mitra, A. K., Gangahar, D. M. & Agrawal, D. K. Cellular, molecular and immunological mechanisms in the pathophysiology of vein graft intimal hyperplasia. Immunol. Cell Biol. 84, 115\u2013124 (2006).","journal-title":"Immunol. Cell Biol."},{"key":"BFnrcardio201676_CR77","doi-asserted-by":"crossref","first-page":"H1200","DOI":"10.1152\/ajpheart.00268.2009","volume":"297","author":"Z Jiang","year":"2009","unstructured":"Jiang, Z. et al. Established neointimal hyperplasia in vein grafts expands via TGF-\u03b2-mediated progressive fibrosis. Am. J. Physiol. Heart Circ. Physiol. 297, H1200\u2013H1207 (2009).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"BFnrcardio201676_CR78","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.jvs.2008.12.020","volume":"49","author":"RD Kenagy","year":"2009","unstructured":"Kenagy, R. D. et al. Proliferative capacity of vein graft smooth muscle cells and fibroblasts in vitro correlates with graft stenosis. J. Vasc. Surg. 49, 1282\u20131288 (2009).","journal-title":"J. Vasc. Surg."},{"key":"BFnrcardio201676_CR79","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1254\/jphs.11242FP","volume":"119","author":"D Jin","year":"2012","unstructured":"Jin, D. et al. Outside fibroblasts play a key role in the development of inner neointima after the implantation of polytetrafluoroethylene grafts. J. Pharmacol. Sci. 119, 139\u2013149 (2012).","journal-title":"J. Pharmacol. Sci."},{"key":"BFnrcardio201676_CR80","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1161\/01.ATV.0000116865.98067.31","volume":"24","author":"L Zhang","year":"2004","unstructured":"Zhang, L., Freedman, N. J., Brian, L. & Peppel, K. Graft-extrinsic cells predominate in vein graft arterialization. Arterioscler. Thromb. Vasc. Biol. 24, 470\u2013476 (2004).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrcardio201676_CR81","doi-asserted-by":"crossref","first-page":"839","DOI":"10.2353\/ajpath.2008.070840","volume":"172","author":"Y Diao","year":"2008","unstructured":"Diao, Y. et al. Long-term engraftment of bone marrow-derived cells in the intimal hyperplasia lesion of autologous vein grafts. Am. J. Pathol. 172, 839\u2013848 (2008).","journal-title":"Am. J. Pathol."},{"key":"BFnrcardio201676_CR82","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s12265-010-9248-9","volume":"4","author":"PJ Psaltis","year":"2011","unstructured":"Psaltis, P. J., Harbuzariu, A., Delacroix, S., Holroyd, E. W. & Simari, R. D. Resident vascular progenitor cells \u2014 diverse origins, phenotype, and function. J. Cardiovasc. Transl. Res. 4, 161\u2013176 (2011).","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"BFnrcardio201676_CR83","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.carpath.2010.04.003","volume":"20","author":"M Jevon","year":"2011","unstructured":"Jevon, M. et al. Smooth muscle cells in porcine vein graft intimal hyperplasia are derived from the local vessel wall. Cardiovasc. Pathol. 20, e91\u2013e94 (2011).","journal-title":"Cardiovasc. Pathol."},{"key":"BFnrcardio201676_CR84","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1161\/ATVBAHA.113.300902","volume":"33","author":"Y Chen","year":"2013","unstructured":"Chen, Y. et al. Adventitial stem cells in vein grafts display multilineage potential that contributes to neointimal formation. Arterioscler. Thromb. Vasc. Biol. 33, 1844\u20131851 (2013).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrcardio201676_CR85","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00395-014-0431-z","volume":"109","author":"M Liang","year":"2014","unstructured":"Liang, M., Liang, A., Wang, Y., Jiang, J. & Cheng, J. Smooth muscle cells from the anastomosed artery are the major precursors for neointima formation in both artery and vein grafts. Basic Res. Cardiol. 109, 431 (2014).","journal-title":"Basic Res. Cardiol."},{"key":"BFnrcardio201676_CR86","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1161\/CIRCULATIONAHA.110.965202","volume":"122","author":"H Iwata","year":"2010","unstructured":"Iwata, H. et al. Bone marrow-derived cells contribute to vascular inflammation but do not differentiate into smooth muscle cell lineages. Circulation 122, 2048\u20132057 (2010).","journal-title":"Circulation"},{"key":"BFnrcardio201676_CR87","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.jvs.2012.03.254","volume":"56","author":"L Zhang","year":"2012","unstructured":"Zhang, L., Brian, L. & Freedman, N. J. Vein graft neointimal hyperplasia is exacerbated by CXCR4 signaling in vein graft-extrinsic cells. J. Vasc. Surg. 56, 1390\u20131397 (2012).","journal-title":"J. Vasc. Surg."},{"key":"BFnrcardio201676_CR88","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/CIRCRESAHA.111.246025","volume":"110","author":"J Cheng","year":"2012","unstructured":"Cheng, J., Wang, Y., Liang, A., Jia, L. & Du, J. FSP-1 silencing in bone marrow cells suppresses neointima formation in vein graft. Circ. Res. 110, 230\u2013240 (2012).","journal-title":"Circ. Res."},{"key":"BFnrcardio201676_CR89","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.amjsurg.2003.07.023","volume":"186","author":"KJ Woodside","year":"2003","unstructured":"Woodside, K. J. et al. Altered expression of vascular endothelial growth factor and its receptors in normal saphenous vein and in arterialized and stenotic vein grafts. Am. J. Surg. 186, 561\u2013568 (2003).","journal-title":"Am. J. Surg."},{"key":"BFnrcardio201676_CR90","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0741-5214(96)80034-6","volume":"23","author":"AV Sterpetti","year":"1996","unstructured":"Sterpetti, A. V. et al. Progression and regression of myointimal hyperplasia in experimental vein grafts depends on platelet-derived growth factor and basic fibroblastic growth factor production. J. Vasc. Surg. 23, 568\u2013575 (1996).","journal-title":"J. Vasc. Surg."},{"key":"BFnrcardio201676_CR91","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.athoracsur.2004.02.066","volume":"78","author":"R Friedl","year":"2004","unstructured":"Friedl, R. et al. Intimal hyperplasia and expression of transforming growth factor-\u03b21 in saphenous veins and internal mammary arteries before coronary artery surgery. Ann. Thorac. Surg. 78, 1312\u20131318 (2004).","journal-title":"Ann. Thorac. Surg."},{"key":"BFnrcardio201676_CR92","first-page":"1060","volume":"117","author":"WJ You","year":"2004","unstructured":"You, W. J., Xiao, M. D. & Yuan, Z. X. Significance of changes in transforming growth factor-\u03b2 mRNA levels in autogenous vein grafts. Chin. Med. J. (Engl.) 117, 1060\u20131065 (2004).","journal-title":"Chin. Med. J. (Engl.)"},{"key":"BFnrcardio201676_CR93","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.phrs.2010.10.018","volume":"63","author":"JY Jeremy","year":"2011","unstructured":"Jeremy, J. Y., Shukla, N., Angelini, G. D. & Wan, S. Endothelin-1 (ET-1) and vein graft failure and the therapeutic potential of ET-1 receptor antagonists. Pharmacol. Res. 63, 483\u2013489 (2011).","journal-title":"Pharmacol. Res."},{"key":"BFnrcardio201676_CR94","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0741-5214(98)70304-0","volume":"27","author":"Z Luo","year":"1998","unstructured":"Luo, Z., Asahara, T., Tsurumi, Y., Isner, J. M. & Symes, J. F. Reduction of vein graft intimal hyperplasia and preservation of endothelium-dependent relaxation by topical vascular endothelial growth factor. J. Vasc. Surg. 27, 167\u2013173 (1998).","journal-title":"J. Vasc. Surg."},{"key":"BFnrcardio201676_CR95","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1161\/01.CIR.100.8.861","volume":"100","author":"Y Hu","year":"1999","unstructured":"Hu, Y., Zou, Y., Dietrich, H., Wick, G. & Xu, Q. Inhibition of neointima hyperplasia of mouse vein grafts by locally applied suramin. Circulation 100, 861\u2013868 (1999).","journal-title":"Circulation"},{"key":"BFnrcardio201676_CR96","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1161\/CIRCULATIONAHA.107.740613","volume":"118","author":"S Kimura","year":"2008","unstructured":"Kimura, S. et al. Local delivery of imatinib mesylate (STI571)-incorporated nanoparticle ex vivo suppresses vein graft neointima formation. Circulation 118, S65\u2013S70 (2008).","journal-title":"Circulation"},{"key":"BFnrcardio201676_CR97","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.jvs.2011.04.037","volume":"54","author":"NK Kapur","year":"2011","unstructured":"Kapur, N. K. et al. Inhibition of transforming growth factor-\u03b2 restores endothelial thromboresistance in vein grafts. J. Vasc. Surg. 54, 1117\u20131123 (2011).","journal-title":"J. Vasc. Surg."},{"key":"BFnrcardio201676_CR98","doi-asserted-by":"crossref","first-page":"e41857","DOI":"10.1371\/journal.pone.0041857","volume":"7","author":"DX Sun","year":"2012","unstructured":"Sun, D. X. et al. Nanoparticle-mediated local delivery of an antisense TGF-\u03b21 construct inhibits intimal hyperplasia in autogenous vein grafts in rats. PLoS ONE 7, e41857 (2012).","journal-title":"PLoS ONE"},{"key":"BFnrcardio201676_CR99","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1161\/01.CIR.97.2.181","volume":"97","author":"Z Yang","year":"1998","unstructured":"Yang, Z. et al. Different proliferative properties of smooth muscle cells of human arterial and venous bypass vessels: role of PDGF receptors, mitogen-activated protein kinase, and cyclin-dependent kinase inhibitors. Circulation 97, 181\u2013187 (1998).","journal-title":"Circulation"},{"key":"BFnrcardio201676_CR100","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.jtcvs.2003.07.017","volume":"127","author":"PC Saunders","year":"2004","unstructured":"Saunders, P. C. et al. Vein graft arterialization causes differential activation of mitogen-activated protein kinases. J. Thorac. Cardiovasc. Surg. 127, 1276\u20131284 (2004).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"BFnrcardio201676_CR101","doi-asserted-by":"crossref","first-page":"e0138587","DOI":"10.1371\/journal.pone.0138587","volume":"10","author":"A Chanakira","year":"2015","unstructured":"Chanakira, A. et al. Hypoxia differentially regulates arterial and venous smooth muscle cell migration. PLoS ONE 10, e0138587 (2015).","journal-title":"PLoS ONE"},{"key":"BFnrcardio201676_CR102","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.hlc.2013.02.006","volume":"22","author":"JJ Ge","year":"2013","unstructured":"Ge, J. J. et al. p38 MAPK inhibitor, CBS3830 limits vascular remodelling in arterialised vein grafts. Heart Lung Circ. 22, 751\u2013758 (2013).","journal-title":"Heart Lung Circ."},{"key":"BFnrcardio201676_CR103","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jvs.2007.01.061","volume":"45","author":"NA Turner","year":"2007","unstructured":"Turner, N. A., Ho, S., Warburton, P., O'Regan, D. J. & Porter, K. E. Smooth muscle cells cultured from human saphenous vein exhibit increased proliferation, invasion, and mitogen-activated protein kinase activation in vitro compared with paired internal mammary artery cells. J. Vasc. Surg. 45, 1022\u20131028 (2007).","journal-title":"J. Vasc. Surg."},{"key":"BFnrcardio201676_CR104","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000099141","volume":"44","author":"S Weiss","year":"2007","unstructured":"Weiss, S. et al. Different migration of vascular smooth muscle cells from human coronary artery bypass vessels. Role of Rho\/ROCK pathway. J. Vasc. Res. 44, 149\u2013156 (2007).","journal-title":"J. Vasc. Res."},{"key":"BFnrcardio201676_CR105","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1161\/ATVBAHA.113.303145","volume":"34","author":"P Li","year":"2014","unstructured":"Li, P. et al. Cross talk between vascular smooth muscle cells and monocytes through interleukin-1\u03b2\/interleukin-18 signaling promotes vein graft thickening. Arterioscler. Thromb. Vasc. Biol. 34, 2001\u20132011 (2014).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrcardio201676_CR106","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1159\/000093606","volume":"43","author":"K Frischknecht","year":"2006","unstructured":"Frischknecht, K. et al. Different vascular smooth muscle cell apoptosis in the human internal mammary artery and the saphenous vein. Implications for bypass graft disease. J. Vasc. Res. 43, 338\u2013346 (2006).","journal-title":"J. Vasc. Res."},{"key":"BFnrcardio201676_CR107","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.jvs.2003.12.031","volume":"39","author":"SA Berceli","year":"2004","unstructured":"Berceli, S. A. et al. Differential expression and activity of matrix metalloproteinases during flow-modulated vein graft remodeling. J. Vasc. Surg. 39, 1084\u20131090 (2004).","journal-title":"J. Vasc. Surg."},{"key":"BFnrcardio201676_CR108","doi-asserted-by":"crossref","first-page":"H1651","DOI":"10.1152\/ajpheart.00530.2005","volume":"290","author":"R Sharony","year":"2006","unstructured":"Sharony, R. et al. Matrix metalloproteinase expression in vein grafts: role of inflammatory mediators and extracellular signal-regulated kinases-1 and -2. Am. J. Physiol. Heart Circ. Physiol. 290, H1651\u2013H1659 (2006).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"BFnrcardio201676_CR109","first-page":"236","volume":"1","author":"JH Lardenoye","year":"2005","unstructured":"Lardenoye, J. H. et al. Inhibition of intimal hyperplasia by the tetracycline derived mmp inhibitor doxycycline in vein graft disease in vitro and in vivo. EuroIntervention 1, 236\u2013243 (2005).","journal-title":"EuroIntervention"},{"key":"BFnrcardio201676_CR110","doi-asserted-by":"crossref","first-page":"730721","DOI":"10.1155\/2013\/730721","volume":"2013","author":"B Perek","year":"2013","unstructured":"Perek, B. et al. Preexisting high expression of matrix metalloproteinase-2 in tunica media of saphenous vein conduits is associated with unfavorable long-term outcomes after coronary artery bypass grafting. Biomed. Res. Int. 2013, 730721 (2013).","journal-title":"Biomed. Res. Int."},{"key":"BFnrcardio201676_CR111","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.atherosclerosis.2006.08.017","volume":"193","author":"NA Turner","year":"2007","unstructured":"Turner, N. A., Hall, K. T., Ball, S. G. & Porter, K. E. Selective gene silencing of either MMP-2 or MMP-9 inhibits invasion of human saphenous vein smooth muscle cells. Atherosclerosis 193, 36\u201343 (2007).","journal-title":"Atherosclerosis"},{"key":"BFnrcardio201676_CR112","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1159\/000265564","volume":"47","author":"AC Thomas","year":"2010","unstructured":"Thomas, A. C. & Newby, A. C. Effect of matrix metalloproteinase-9 knockout on vein graft remodelling in mice. J. Vasc. Res. 47, 299\u2013308 (2010).","journal-title":"J. Vasc. Res."},{"key":"BFnrcardio201676_CR113","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1038\/sj.gt.3300764","volume":"5","author":"SJ George","year":"1998","unstructured":"George, S. J., Baker, A. H., Angelini, G. D. & Newby, A. C. Gene transfer of tissue inhibitor of metalloproteinase-2 inhibits metalloproteinase activity and neointima formation in human saphenous veins. Gene Ther. 5, 1552\u20131560 (1998).","journal-title":"Gene Ther."},{"key":"BFnrcardio201676_CR114","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1089\/hum.1998.9.6-867","volume":"9","author":"SJ George","year":"1998","unstructured":"George, S. J., Johnson, J. L., Angelini, G. D., Newby, A. C. & Baker, A. H. Adenovirus-mediated gene transfer of the human TIMP-1 gene inhibits smooth muscle cell migration and neointimal formation in human saphenous vein. Hum. Gene Ther. 9, 867\u2013877 (1998).","journal-title":"Hum. Gene Ther."},{"key":"BFnrcardio201676_CR115","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1161\/01.CIR.101.3.296","volume":"101","author":"SJ George","year":"2000","unstructured":"George, S. J., Lloyd, C. T., Angelini, G. D., Newby, A. C. & Baker, A. H. Inhibition of late vein graft neointima formation in human and porcine models by adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-3. Circulation 101, 296\u2013304 (2000).","journal-title":"Circulation"},{"key":"BFnrcardio201676_CR116","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1161\/hq0801.093658","volume":"21","author":"Y Hu","year":"2001","unstructured":"Hu, Y., Baker, A. H., Zou, Y., Newby, A. C. & Xu, Q. Local gene transfer of tissue inhibitor of metalloproteinase-2 influences vein graft remodeling in a mouse model. Arterioscler. Thromb. Vasc. Biol. 21, 1275\u20131280 (2001).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrcardio201676_CR117","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.1161\/CIRCULATIONAHA.110.012732","volume":"124","author":"SJ George","year":"2011","unstructured":"George, S. J. et al. Sustained reduction of vein graft neointima formation by ex vivo TIMP-3 gene therapy. Circulation 124, S135\u2013S142 (2011).","journal-title":"Circulation"},{"key":"BFnrcardio201676_CR118","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jvs.2004.12.037","volume":"41","author":"RA Wolff","year":"2005","unstructured":"Wolff, R. A. et al. Antisense to transforming growth factor-\u03b21 messenger RNA reduces vein graft intimal hyperplasia and monocyte chemotactic protein 1. J. Vasc. Surg. 41, 498\u2013508 (2005).","journal-title":"J. Vasc. Surg."},{"key":"BFnrcardio201676_CR119","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1161\/01.RES.0000199263.67107.c0","volume":"98","author":"M van den Boom","year":"2006","unstructured":"van den Boom, M. et al. Differential regulation of hyaluronic acid synthase isoforms in human saphenous vein smooth muscle cells: possible implications for vein graft stenosis. Circ. Res. 98, 36\u201344 (2006).","journal-title":"Circ. Res."},{"key":"BFnrcardio201676_CR120","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1161\/01.CIR.96.6.1783","volume":"96","author":"P Kauhanen","year":"1997","unstructured":"Kauhanen, P. et al. Plasminogen activator inhibitor-1 in neointima of vein grafts: its role in reduced fibrinolytic potential and graft failure. Circulation 96, 1783\u20131789 (1997).","journal-title":"Circulation"},{"key":"BFnrcardio201676_CR121","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00001721-200306000-00008","volume":"14","author":"V Siren","year":"2003","unstructured":"Siren, V. et al. Urokinase, tissue-type plasminogen activator and plasminogen activator inhibitor-1 expression in severely stenosed and occluded vein grafts with thrombosis. Blood Coagul. Fibrinolysis 14, 369\u2013377 (2003).","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"BFnrcardio201676_CR122","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1161\/ATVBAHA.107.140046","volume":"27","author":"WP Fay","year":"2007","unstructured":"Fay, W. P., Garg, N. & Sunkar, M. Vascular functions of the plasminogen activation system. Arterioscler. Thromb. Vasc. Biol. 27, 1231\u20131237 (2007).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrcardio201676_CR123","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1161\/01.RES.81.5.829","volume":"81","author":"P Carmeliet","year":"1997","unstructured":"Carmeliet, P. et al. Urokinase but not tissue plasminogen activator mediates arterial neointima formation in mice. Circ. Res. 81, 829\u2013839 (1997).","journal-title":"Circ. Res."},{"key":"BFnrcardio201676_CR124","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1160\/TH08-11-0772","volume":"102","author":"AC Thomas","year":"2009","unstructured":"Thomas, A. C., Wyatt, M. J. & Newby, A. C. Reduction of early vein graft thrombosis by tissue plasminogen activator gene transfer. Thromb. Haemost. 102, 145\u2013152 (2009).","journal-title":"Thromb. Haemost."},{"key":"BFnrcardio201676_CR125","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1160\/TH08-07-0473","volume":"100","author":"I Diebold","year":"2008","unstructured":"Diebold, I., Kraicun, D., Bonello, S. & Gorlach, A. The 'PAI-1 paradox' in vascular remodeling. Thromb. Haemost. 100, 984\u2013991 (2008).","journal-title":"Thromb. Haemost."},{"key":"BFnrcardio201676_CR126","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1161\/ATVBAHA.111.228767","volume":"31","author":"Y Ji","year":"2011","unstructured":"Ji, Y. et al. Multifaceted role of plasminogen activator inhibitor-1 in regulating early remodeling of vein bypass grafts. Arterioscler. Thromb. Vasc. Biol. 31, 1781\u20131787 (2011).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrcardio201676_CR127","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1161\/01.RES.0000041418.51906.57","volume":"91","author":"ML Lamfers","year":"2002","unstructured":"Lamfers, M. L. et al. Gene transfer of the urokinase-type plasminogen activator receptor-targeted matrix metalloproteinase inhibitor TIMP-1.ATF suppresses neointima formation more efficiently than tissue inhibitor of metalloproteinase-1. Circ. Res. 91, 945\u2013952 (2002).","journal-title":"Circ. Res."},{"key":"BFnrcardio201676_CR128","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jvs.2009.09.026","volume":"51","author":"D Eefting","year":"2010","unstructured":"Eefting, D. et al. In vivo suppression of vein graft disease by nonviral, electroporation-mediated, gene transfer of tissue inhibitor of metalloproteinase-1 linked to the amino terminal fragment of urokinase (TIMP-1.ATF), a cell-surface directed matrix metalloproteinase inhibitor. J. Vasc. Surg. 51, 429\u2013437 (2010).","journal-title":"J. Vasc. Surg."},{"key":"BFnrcardio201676_CR129","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/cvr\/cvq203","volume":"88","author":"D Eefting","year":"2010","unstructured":"Eefting, D. et al. A novel urokinase receptor-targeted inhibitor for plasmin and matrix metalloproteinases suppresses vein graft disease. Cardiovasc. Res. 88, 367\u2013375 (2010).","journal-title":"Cardiovasc. Res."},{"key":"BFnrcardio201676_CR130","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1161\/01.CIR.103.4.562","volume":"103","author":"PH Quax","year":"2001","unstructured":"Quax, P. H. et al. Adenoviral expression of a urokinase receptor-targeted protease inhibitor inhibits neointima formation in murine and human blood vessels. Circulation 103, 562\u2013569 (2001).","journal-title":"Circulation"},{"key":"BFnrcardio201676_CR131","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jvs.2005.11.019","volume":"43","author":"A Schepers","year":"2006","unstructured":"Schepers, A. et al. Short-term dexamethasone treatment inhibits vein graft thickening in hypercholesterolemic ApoE3Leiden transgenic mice. J. Vasc. Surg. 43, 809\u2013815 (2006).","journal-title":"J. Vasc. Surg."},{"key":"BFnrcardio201676_CR132","doi-asserted-by":"crossref","first-page":"A92","DOI":"10.1016\/j.jvs.2007.02.032","volume":"45","author":"CK Ozaki","year":"2007","unstructured":"Ozaki, C. K. Cytokines and the early vein graft: strategies to enhance durability. J. Vasc. Surg. 45, A92\u2013A98 (2007).","journal-title":"J. Vasc. Surg."},{"key":"BFnrcardio201676_CR133","doi-asserted-by":"crossref","first-page":"672395","DOI":"10.1155\/2010\/672395","volume":"2010","author":"AM Piccinini","year":"2010","unstructured":"Piccinini, A. M. & Midwood, K. S. DAMPening inflammation by modulating TLR signalling. Mediators. Inflamm. 2010, 672395 (2010).","journal-title":"Mediators. Inflamm."},{"key":"BFnrcardio201676_CR134","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1161\/ATVBAHA.111.223271","volume":"31","author":"JC Karper","year":"2011","unstructured":"Karper, J. C. et al. Toll-like receptor 4 is involved in human and mouse vein graft remodeling, and local gene silencing reduces vein graft disease in hypercholesterolemic APOE*3Leiden mice. Arterioscler. Thromb. Vasc. Biol. 31, 1033\u20131040 (2011).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrcardio201676_CR135","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.athoracsur.2011.10.035","volume":"93","author":"MS Khaleel","year":"2012","unstructured":"Khaleel, M. S. et al. High-pressure distention of the saphenous vein during preparation results in increased markers of inflammation: a potential mechanism for graft failure. Ann. Thorac. Surg. 93, 552\u2013558 (2012).","journal-title":"Ann. Thorac. Surg."},{"key":"BFnrcardio201676_CR136","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1161\/01.CIR.0000109140.51366.72","volume":"109","author":"SC Hollestelle","year":"2004","unstructured":"Hollestelle, S. C. et al. Toll-like receptor 4 is involved in outward arterial remodeling. Circulation 109, 393\u2013398 (2004).","journal-title":"Circulation"},{"key":"BFnrcardio201676_CR137","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jvs.2013.04.042","volume":"58","author":"M Sobel","year":"2013","unstructured":"Sobel, M. et al. Low levels of a natural IgM antibody are associated with vein graft stenosis and failure. J. Vasc. Surg. 58, 997\u20131005 (2013).","journal-title":"J. Vasc. Surg."},{"key":"BFnrcardio201676_CR138","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.atherosclerosis.2005.11.033","volume":"189","author":"JR Faria-Neto","year":"2006","unstructured":"Faria-Neto, J. R. et al. Passive immunization with monoclonal IgM antibodies against phosphorylcholine reduces accelerated vein graft atherosclerosis in apolipoprotein E-null mice. Atherosclerosis 189, 83\u201390 (2006).","journal-title":"Atherosclerosis"},{"key":"BFnrcardio201676_CR139","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","volume":"11","author":"T Kawai","year":"2010","unstructured":"Kawai, T. & Akira, S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11, 373\u2013384 (2010).","journal-title":"Nat. Immunol."},{"key":"BFnrcardio201676_CR140","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/S0003-4975(02)03921-8","volume":"74","author":"T Shintani","year":"2002","unstructured":"Shintani, T. et al. Intraoperative transfection of vein grafts with the NF\u03baB decoy in a canine aortocoronary bypass model: a strategy to attenuate intimal hyperplasia. Ann. Thorac. Surg. 74, 1132\u20131137 (2002).","journal-title":"Ann. Thorac. Surg."},{"key":"BFnrcardio201676_CR141","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.yjmcc.2006.04.006","volume":"41","author":"T Miyake","year":"2006","unstructured":"Miyake, T. et al. Inhibitory effects of NF\u03baB decoy oligodeoxynucleotides on neointimal hyperplasia in a rabbit vein graft model. J. Mol. Cell. Cardiol. 41, 431\u2013440 (2006).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"BFnrcardio201676_CR142","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1016\/j.transproceed.2013.03.045","volume":"45","author":"XB Meng","year":"2013","unstructured":"Meng, X. B. et al. Small interfering RNA targeting nuclear factor kappa B to prevent vein graft stenosis in rat models. Transplant. Proc. 45, 2553\u20132558 (2013).","journal-title":"Transplant. Proc."},{"key":"BFnrcardio201676_CR143","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.jvs.2007.01.066","volume":"45","author":"H Tatewaki","year":"2007","unstructured":"Tatewaki, H. et al. Blockade of monocyte chemoattractant protein-1 by adenoviral gene transfer inhibits experimental vein graft neointimal formation. J. Vasc. Surg. 45, 1236\u20131243 (2007).","journal-title":"J. Vasc. Surg."},{"key":"BFnrcardio201676_CR144","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1161\/ATVBAHA.112.255786","volume":"32","author":"C Fu","year":"2012","unstructured":"Fu, C. et al. Monocyte chemoattractant protein-1\/CCR2 axis promotes vein graft neointimal hyperplasia through its signaling in graft-extrinsic cell populations. Arterioscler. Thromb. Vasc. Biol. 32, 2418\u20132426 (2012).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrcardio201676_CR145","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1161\/01.ATV.0000235694.69719.e2","volume":"26","author":"A Schepers","year":"2006","unstructured":"Schepers, A. et al. Anti-MCP-1 gene therapy inhibits vascular smooth muscle cells proliferation and attenuates vein graft thickening both in vitro and in vivo. Arterioscler. Thromb. Vasc. Biol. 26, 2063\u20132069 (2006).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrcardio201676_CR146","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1161\/01.ATV.0000147766.68987.0d","volume":"24","author":"L Zhang","year":"2004","unstructured":"Zhang, L., Peppel, K., Brian, L., Chien, L. & Freedman, N. J. Vein graft neointimal hyperplasia is exacerbated by tumor necrosis factor receptor-1 signaling in graft-intrinsic cells. Arterioscler. Thromb. Vasc. Biol. 24, 2277\u20132283 (2004).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrcardio201676_CR147","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1161\/ATVBAHA.107.151613","volume":"28","author":"L Zhang","year":"2008","unstructured":"Zhang, L. et al. Tumor necrosis factor receptor-2 signaling attenuates vein graft neointima formation by promoting endothelial recovery. Arterioscler. Thromb. Vasc. Biol. 28, 284\u2013289 (2008).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrcardio201676_CR148","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0741-5214(96)70203-3","volume":"24","author":"PL Faries","year":"1996","unstructured":"Faries, P. L. et al. Immunolocalization and temporal distribution of cytokine expression during the development of vein graft intimal hyperplasia in an experimental model. J. Vasc. Surg. 24, 463\u2013471 (1996).","journal-title":"J. Vasc. Surg."},{"key":"BFnrcardio201676_CR149","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0039-6060(98)70169-2","volume":"123","author":"AV Sterpetti","year":"1998","unstructured":"Sterpetti, A. V. et al. Formation of myointimal hyperplasia and cytokine production in experimental vein grafts. Surgery 123, 461\u2013469 (1998).","journal-title":"Surgery"},{"key":"BFnrcardio201676_CR150","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jvs.2004.03.048","volume":"40","author":"Z Jiang","year":"2004","unstructured":"Jiang, Z. et al. Wall shear modulation of cytokines in early vein grafts. J. Vasc. Surg. 40, 345\u2013350 (2004).","journal-title":"J. Vasc. Surg."},{"key":"BFnrcardio201676_CR151","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1161\/CIRCULATIONAHA.106.619502","volume":"114","author":"A Schepers","year":"2006","unstructured":"Schepers, A. et al. Inhibition of complement component C3 reduces vein graft atherosclerosis in apolipoprotein E3-Leiden transgenic mice. Circulation 114, 2831\u20132838 (2006).","journal-title":"Circulation"},{"key":"BFnrcardio201676_CR152","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.atherosclerosis.2011.10.021","volume":"220","author":"PA Krijnen","year":"2012","unstructured":"Krijnen, P. A. et al. C1-esterase inhibitor protects against early vein graft remodeling under arterial blood pressure. Atherosclerosis 220, 86\u201392 (2012).","journal-title":"Atherosclerosis"},{"key":"BFnrcardio201676_CR153","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/cvr\/cvs312","volume":"97","author":"MR de Vries","year":"2013","unstructured":"de Vries, M. R. et al. Complement factor C5a as mast cell activator mediates vascular remodelling in vein graft disease. Cardiovasc. Res. 97, 311\u2013320 (2013).","journal-title":"Cardiovasc. Res."},{"key":"BFnrcardio201676_CR154","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jtcvs.2010.08.035","volume":"142","author":"PK Smith","year":"2011","unstructured":"Smith, P. K. et al. Effects of C5 complement inhibitor pexelizumab on outcome in high-risk coronary artery bypass grafting: combined results from the PRIMO-CABG I and II trials. J. Thorac. Cardiovasc. Surg. 142, 89\u201398 (2011).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"BFnrcardio201676_CR155","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/j.athoracsur.2012.04.132","volume":"94","author":"MR Dashwood","year":"2012","unstructured":"Dashwood, M. R. Distension of the saphenous vein during graft preparation: markers of inflammation or endothelium? Ann. Thorac. Surg. 94, 2177\u20132178 (2012).","journal-title":"Ann. Thorac. Surg."},{"key":"BFnrcardio201676_CR156","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.athoracsur.2005.09.073","volume":"81","author":"A Schlitt","year":"2006","unstructured":"Schlitt, A. et al. Neutrophil adherence to activated saphenous vein and mammary endothelium after graft preparation. Ann. Thorac. Surg. 81, 1262\u20131268 (2006).","journal-title":"Ann. Thorac. Surg."},{"key":"BFnrcardio201676_CR157","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1160\/TH11-07-0501","volume":"106","author":"M Drechsler","year":"2011","unstructured":"Drechsler, M., Doring, Y., Megens, R. T. & Soehnlein, O. Neutrophilic granulocytes \u2014 promiscuous accelerators of atherosclerosis. Thromb. Haemost. 106, 839\u2013848 (2011).","journal-title":"Thromb. Haemost."},{"key":"BFnrcardio201676_CR158","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00418-012-1069-2","volume":"140","author":"A Malinska","year":"2013","unstructured":"Malinska, A. et al. CD68 expression in aortocoronary saphenous vein bypass grafts. Histochem. Cell Biol. 140, 183\u2013188 (2013).","journal-title":"Histochem. Cell Biol."},{"key":"BFnrcardio201676_CR159","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00281-009-0153-8","volume":"31","author":"RR Packard","year":"2009","unstructured":"Packard, R. R., Lichtman, A. H. & Libby, P. Innate and adaptive immunity in atherosclerosis. Semin. Immunopathol. 31, 5\u201322 (2009).","journal-title":"Semin. Immunopathol."},{"key":"BFnrcardio201676_CR160","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1161\/ATVBAHA.110.216747","volume":"31","author":"MM Ewing","year":"2011","unstructured":"Ewing, M. M. et al. Annexin A5 therapy attenuates vascular inflammation and remodeling and improves endothelial function in mice. Arterioscler. Thromb. Vasc. Biol. 31, 95\u2013101 (2011).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrcardio201676_CR161","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1161\/ATVBAHA.115.305516","volume":"35","author":"J Koga","year":"2015","unstructured":"Koga, J. et al. Macrophage Notch ligand Delta-like 4 promotes vein graft lesion development: implications for the treatment of vein graft failure. Arterioscler. Thromb. Vasc. Biol. 35, 2343\u20132353 (2015).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrcardio201676_CR162","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0967-2109(00)00102-2","volume":"9","author":"SM Cherian","year":"2001","unstructured":"Cherian, S. M. et al. Immunohistochemical and ultrastructural evidence that dendritic cells infiltrate stenotic aortocoronary saphenous vein bypass grafts. Cardiovasc. Surg. 9, 194\u2013200 (2001).","journal-title":"Cardiovasc. Surg."},{"key":"BFnrcardio201676_CR163","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cell.2011.04.005","volume":"145","author":"KJ Moore","year":"2011","unstructured":"Moore, K. J. & Tabas, I. Macrophages in the pathogenesis of atherosclerosis. Cell 145, 341\u2013355 (2011).","journal-title":"Cell"},{"key":"BFnrcardio201676_CR164","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0967-2109(00)00141-1","volume":"9","author":"J Ozmen","year":"2001","unstructured":"Ozmen, J., Bobryshev, Y. V. & Lord, R. S. CD40 co-stimulatory molecule expression by dendritic cells in primary atherosclerotic lesions in carotid arteries and in stenotic saphenous vein coronary artery grafts. Cardiovasc. Surg. 9, 329\u2013333 (2001).","journal-title":"Cardiovasc. Surg."},{"key":"BFnrcardio201676_CR165","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nrcardio.2015.117","volume":"12","author":"GP Shi","year":"2015","unstructured":"Shi, G. P., Bot, I. & Kovanen, P. T. Mast cells in human and experimental cardiometabolic diseases. Nat. Rev. Cardiol. 12, 643\u2013658 (2015).","journal-title":"Nat. Rev. Cardiol."},{"key":"BFnrcardio201676_CR166","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/1523-1747.ep12378589","volume":"102","author":"SG el-Lati","year":"1994","unstructured":"el-Lati, S. G., Dahinden, C. A. & Church, M. K. Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells. J. Invest. Dermatol. 102, 803\u2013806 (1994).","journal-title":"J. Invest. Dermatol."},{"key":"BFnrcardio201676_CR167","first-page":"171","volume":"104","author":"KS Cross","year":"1988","unstructured":"Cross, K. S. et al. Mast cell infiltration: a possible mechanism for vein graft vasospasm. Surgery 104, 171\u2013177 (1988).","journal-title":"Surgery"},{"key":"BFnrcardio201676_CR168","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1042\/BST0350857","volume":"35","author":"PT Kovanen","year":"2007","unstructured":"Kovanen, P. T. Mast cells and degradation of pericellular and extracellular matrices: potential contributions to erosion, rupture and intraplaque haemorrhage of atherosclerotic plaques. Biochem. Soc. Trans. 35, 857\u2013861 (2007).","journal-title":"Biochem. Soc. Trans."},{"key":"BFnrcardio201676_CR169","doi-asserted-by":"crossref","first-page":"113","DOI":"10.5482\/HAMO-14-08-0034","volume":"35","author":"A Wezel","year":"2015","unstructured":"Wezel, A., Quax, P. H., Kuiper, J. & Bot, I. The role of mast cells in atherosclerosis. Hamostaseologie 35, 113\u2013120 (2015).","journal-title":"Hamostaseologie"},{"key":"BFnrcardio201676_CR170","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1161\/ATVBAHA.107.161224","volume":"28","author":"A Schober","year":"2008","unstructured":"Schober, A. Chemokines in vascular dysfunction and remodeling. Arterioscler. Thromb. Vasc. Biol. 28, 1950\u20131959 (2008).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrcardio201676_CR171","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.yjmcc.2013.08.009","volume":"64","author":"MR de Vries","year":"2013","unstructured":"de Vries, M. R. et al. C57BL\/6 NK cell gene complex is crucially involved in vascular remodeling. J. Mol. Cell. Cardiol. 64, 51\u201358 (2013).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"BFnrcardio201676_CR172","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0741-5214(98)70323-4","volume":"27","author":"JP Carpenter","year":"1998","unstructured":"Carpenter, J. P. & Tomaszewski, J. E. Human saphenous vein allograft bypass grafts: immune response. J. Vasc. Surg. 27, 492\u2013499 (1998).","journal-title":"J. Vasc. Surg."},{"key":"BFnrcardio201676_CR173","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.clim.2009.07.002","volume":"134","author":"J Andersson","year":"2010","unstructured":"Andersson, J., Libby, P. & Hansson, G. K. Adaptive immunity and atherosclerosis. Clin. Immunol. 134, 33\u201346 (2010).","journal-title":"Clin. Immunol."},{"key":"BFnrcardio201676_CR174","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.ijcard.2012.12.085","volume":"168","author":"MM Ewing","year":"2013","unstructured":"Ewing, M. M. et al. T-cell co-stimulation by CD28\u2013CD80\/86 and its negative regulator CTLA-4 strongly influence accelerated atherosclerosis development. Int. J. Cardiol. 168, 1965\u20131974 (2013).","journal-title":"Int. J. Cardiol."},{"key":"BFnrcardio201676_CR175","first-page":"671","volume":"14","author":"JW Butany","year":"1998","unstructured":"Butany, J. W., David, T. E. & Ojha, M. Histological and morphometric analyses of early and late aortocoronary vein grafts and distal anastomoses. Can. J. Cardiol. 14, 671\u2013677 (1998).","journal-title":"Can. J. Cardiol."},{"key":"BFnrcardio201676_CR176","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jss.2014.01.042","volume":"188","author":"DY Lu","year":"2014","unstructured":"Lu, D. Y. et al. Vein graft adaptation and fistula maturation in the arterial environment. J. Surg. Res. 188, 162\u2013173 (2014).","journal-title":"J. Surg. Res."},{"key":"BFnrcardio201676_CR177","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1253\/circj.CJ-10-0495","volume":"74","author":"A Muto","year":"2010","unstructured":"Muto, A., Model, L., Ziegler, K., Eghbalieh, S. D. & Dardik, A. Mechanisms of vein graft adaptation to the arterial circulation: insights into the neointimal algorithm and management strategies. Circ. J. 74, 1501\u20131512 (2010).","journal-title":"Circ. J."},{"key":"BFnrcardio201676_CR178","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0741-5214(97)70322-7","volume":"25","author":"A Westerband","year":"1997","unstructured":"Westerband, A. et al. Immunocytochemical determination of cell type and proliferation rate in human vein graft stenoses. J. Vasc. Surg. 25, 64\u201373 (1997).","journal-title":"J. Vasc. Surg."},{"key":"BFnrcardio201676_CR179","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.jvs.2011.04.039","volume":"54","author":"K Moreno","year":"2011","unstructured":"Moreno, K. et al. Circulating inflammatory cells are associated with vein graft stenosis. J. Vasc. Surg. 54, 1124\u20131130 (2011).","journal-title":"J. Vasc. Surg."},{"key":"BFnrcardio201676_CR180","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jcin.2011.12.017","volume":"5","author":"SK Yazdani","year":"2012","unstructured":"Yazdani, S. K. et al. Pathology of drug-eluting versus bare-metal stents in saphenous vein bypass graft lesions. JACC Cardiovasc. Interv. 5, 666\u2013674 (2012).","journal-title":"JACC Cardiovasc. Interv."},{"key":"BFnrcardio201676_CR181","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1111\/jcmm.12357","volume":"18","author":"A Wezel","year":"2014","unstructured":"Wezel, A. et al. Complement factor C5a induces atherosclerotic plaque disruptions. J. Cell. Mol. Med. 18, 2020\u20132030 (2014).","journal-title":"J. Cell. Mol. Med."},{"key":"BFnrcardio201676_CR182","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.athoracsur.2011.05.038","volume":"92","author":"J Li","year":"2011","unstructured":"Li, J. et al. The patency of sequential and individual vein coronary bypass grafts: a systematic review. Ann. Thorac. Surg. 92, 1292\u20131298 (2011).","journal-title":"Ann. Thorac. Surg."},{"key":"BFnrcardio201676_CR183","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3109\/14017439609107239","volume":"30","author":"D Souza","year":"1996","unstructured":"Souza, D. A new no-touch preparation technique. Technical notes. Scand. J. Thorac. Cardiovasc. Surg. 30, 41\u201344 (1996).","journal-title":"Scand. J. Thorac. Cardiovasc. Surg."},{"key":"BFnrcardio201676_CR184","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/S0003-4975(02)03425-2","volume":"73","author":"DS Souza","year":"2002","unstructured":"Souza, D. S. et al. Improved patency in vein grafts harvested with surrounding tissue: results of a randomized study using three harvesting techniques. Ann. Thorac. Surg. 73, 1189\u20131195 (2002).","journal-title":"Ann. Thorac. Surg."},{"key":"BFnrcardio201676_CR185","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jtcvs.2006.04.002","volume":"132","author":"DS Souza","year":"2006","unstructured":"Souza, D. S. et al. Harvesting the saphenous vein with surrounding tissue for CABG provides long-term graft patency comparable to the left internal thoracic artery: results of a randomized longitudinal trial. J. Thorac. Cardiovasc. Surg. 132, 373\u2013378 (2006).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"BFnrcardio201676_CR186","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/ejcts\/ezt560","volume":"45","author":"S Verma","year":"2014","unstructured":"Verma, S. et al. Pedicled no-touch saphenous vein graft harvest limits vascular smooth muscle cell activation: the PATENT saphenous vein graft study. Eur. J. Cardiothorac. Surg. 45, 717\u2013725 (2014).","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"BFnrcardio201676_CR187","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.jtcvs.2015.07.027","volume":"150","author":"N Samano","year":"2015","unstructured":"Samano, N. et al. The no-touch saphenous vein for coronary artery bypass grafting maintains a patency, after 16 years, comparable to the left internal thoracic artery: a randomized trial. J. Thorac. Cardiovasc. Surg. 150, 880\u2013888 (2015).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"BFnrcardio201676_CR188","unstructured":"US National Library of Science. ClinicalTrials.gov http:\/\/clinicaltrials.gov\/show\/NCT01047449 (2016)."},{"key":"BFnrcardio201676_CR189","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/01.gim.0000196315.32179.82","volume":"1","author":"K Allen","year":"2005","unstructured":"Allen, K. et al. Endoscopic vascular harvest in coronary artery bypass grafting surgery: a consensus statement of the International Society of Minimally Invasive Cardiothoracic Surgery (ISMICS) 2005. Innovations (Phila.) 1, 51\u201360 (2005).","journal-title":"Innovations (Phila.)"},{"key":"BFnrcardio201676_CR190","first-page":"475","volume":"308","author":"JB Williams","year":"2012","unstructured":"Williams, J. B. et al. Association between endoscopic versus open vein-graft harvesting and mortality, wound complications, and cardiovascular events in patients undergoing CABG surgery. JAMA 308, 475\u2013484 (2012).","journal-title":"JAMA"},{"key":"BFnrcardio201676_CR191","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jtcvs.2010.10.004","volume":"141","author":"MA Zenati","year":"2011","unstructured":"Zenati, M. A. et al. Impact of endoscopic versus open saphenous vein harvest technique on late coronary artery bypass grafting patient outcomes in the ROOBY (Randomized On\/Off Bypass) Trial. J. Thorac. Cardiovasc. Surg. 141, 338\u2013344 (2011).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"BFnrcardio201676_CR192","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/SLA.0000000000000377","volume":"260","author":"DS van","year":"2014","unstructured":"van, D. S. et al. Endoscopic harvesting device type and outcomes in patients undergoing coronary artery bypass surgery. Ann. Surg. 260, 402\u2013408 (2014).","journal-title":"Ann. Surg."},{"key":"BFnrcardio201676_CR193","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.jvs.2014.12.049","volume":"61","author":"PG Teixeira","year":"2015","unstructured":"Teixeira, P. G., Woo, K., Weaver, F. A. & Rowe, V. L. Vein harvesting technique for infrainguinal arterial bypass with great saphenous vein and its association with surgical site infection and graft patency. J. Vasc. Surg. 61, 1264\u20131271 (2015).","journal-title":"J. Vasc. Surg."},{"key":"BFnrcardio201676_CR194","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1136\/heartjnl-2011-300600","volume":"98","author":"SW Grant","year":"2012","unstructured":"Grant, S. W. et al. What is the impact of endoscopic vein harvesting on clinical outcomes following coronary artery bypass graft surgery? Heart 98, 60\u201364 (2012).","journal-title":"Heart"},{"key":"BFnrcardio201676_CR195","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jss.2012.11.013","volume":"180","author":"AC Deppe","year":"2013","unstructured":"Deppe, A. C. et al. Endoscopic vein harvesting for coronary artery bypass grafting: a systematic review with meta-analysis of 27,789 patients. J. Surg. Res. 180, 114\u2013124 (2013).","journal-title":"J. Surg. Res."},{"key":"BFnrcardio201676_CR196","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/clc.22267","volume":"37","author":"MA Zenati","year":"2014","unstructured":"Zenati, M. A. et al. Choice of vein-harvest technique for coronary artery bypass grafting: rationale and design of the REGROUP trial. Clin. Cardiol. 37, 325\u2013330 (2014).","journal-title":"Clin. Cardiol."},{"key":"BFnrcardio201676_CR197","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.surg.2015.03.036","volume":"158","author":"ES Wise","year":"2015","unstructured":"Wise, E. S. et al. Preservation solution impacts physiologic function and cellular viability of human saphenous vein graft. Surgery 158, 537\u2013546 (2015).","journal-title":"Surgery"},{"key":"BFnrcardio201676_CR198","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1093\/icvts\/ivs275","volume":"15","author":"M Tsakok","year":"2012","unstructured":"Tsakok, M., Montgomery-Taylor, S. & Tsakok, T. Storage of saphenous vein grafts prior to coronary artery bypass grafting: is autologous whole blood more effective than saline in preserving graft function? Interact. Cardiovasc. Thorac. Surg. 15, 720\u2013725 (2012).","journal-title":"Interact. Cardiovasc. Thorac. Surg."},{"key":"BFnrcardio201676_CR199","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0022-5223(95)70417-5","volume":"109","author":"DA Barber","year":"1995","unstructured":"Barber, D. A., Rubin, J. W., Zumbro, G. L. & Tackett, R. L. The use of methylene blue as an extravascular surgical marker impairs vascular responses of human saphenous veins. J. Thorac. Cardiovasc. Surg. 109, 21\u201329 (1995).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"BFnrcardio201676_CR200","doi-asserted-by":"publisher","unstructured":"Hocking, K. M. et al. Brilliant blue FCF is a nontoxic dye for saphenous vein graft marking that abrogates response to injury. J. Vasc. Surg. http:\/\/dx.doi.org\/10.1016\/j.jvs.2014.12.059 (2015).","DOI":"10.1016\/j.jvs.2014.12.059"},{"key":"BFnrcardio201676_CR201","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1053\/j.semvascsurg.2009.10.004","volume":"22","author":"MS Conte","year":"2009","unstructured":"Conte, M. S. Technical factors in lower-extremity vein bypass surgery: how can we improve outcomes? Semin. Vasc. Surg. 22, 227\u2013233 (2009).","journal-title":"Semin. Vasc. Surg."},{"key":"BFnrcardio201676_CR202","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF01616317","volume":"8","author":"VS Sottiurai","year":"1999","unstructured":"Sottiurai, V. S. Comparison of reversed, nonreversed translocated, and in situ vein grafts in arterial revascularization: techniques, cumulative patency, versatility, and durability. Int. J. Angiol. 8, 197\u2013202 (1999).","journal-title":"Int. J. Angiol."},{"key":"BFnrcardio201676_CR203","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0741-5214(91)90211-C","volume":"13","author":"KR Wengerter","year":"1991","unstructured":"Wengerter, K. R. et al. Prospective randomized multicenter comparison of in situ and reversed vein infrapopliteal bypasses. J. Vasc. Surg. 13, 189\u2013197 (1991).","journal-title":"J. Vasc. Surg."},{"key":"BFnrcardio201676_CR204","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1016\/S0828-282X(09)70486-6","volume":"25","author":"P Parang","year":"2009","unstructured":"Parang, P. & Arora, R. Coronary vein graft disease: pathogenesis and prevention. Can. J. Cardiol. 25, e57\u2013e62 (2009).","journal-title":"Can. J. Cardiol."},{"key":"BFnrcardio201676_CR205","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1056\/NEJM197911013011803","volume":"301","author":"GA Pantely","year":"1979","unstructured":"Pantely, G. A. et al. Failure of antiplatelet and anticoagulant therapy to improve patency of grafts after coronary-artery bypass: a controlled, randomized study. N. Engl. J. Med. 301, 962\u2013966 (1979).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201676_CR206","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0022-5223(19)37328-3","volume":"83","author":"MT McEnany","year":"1982","unstructured":"McEnany, M. T. et al. The effect of antithrombotic therapy on patency rates of saphenous vein coronary artery bypass grafts. J. Thorac. Cardiovasc. Surg. 83, 81\u201389 (1982).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"BFnrcardio201676_CR207","first-page":"II218","volume":"68","author":"GV Sharma","year":"1983","unstructured":"Sharma, G. V., Khuri, S. F., Josa, M., Folland, E. D. & Parisi, A. F. The effect of antiplatelet therapy on saphenous vein coronary artery bypass graft patency. Circulation 68, II218\u2013II221 (1983).","journal-title":"Circulation"},{"key":"BFnrcardio201676_CR208","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1161\/01.CIR.80.5.1190","volume":"80","author":"S Goldman","year":"1989","unstructured":"Goldman, S. et al. Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative Study. Circulation 80, 1190\u20131197 (1989).","journal-title":"Circulation"},{"key":"BFnrcardio201676_CR209","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM198401263100401","volume":"310","author":"JH Chesebro","year":"1984","unstructured":"Chesebro, J. H. et al. Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations. N. Engl. J. Med. 310, 209\u2013214 (1984).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201676_CR210","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","volume":"35","author":"S Windecker","year":"2014","unstructured":"Windecker, S. et al. 2014 ESC\/EACTS guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur. Heart J. 35, 2541\u20132619 (2014).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio201676_CR211","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0003-4975(10)60757-6","volume":"37","author":"M Chevigne","year":"1984","unstructured":"Chevigne, M., David, J. L., Rigo, P. & Limet, R. Effect of ticlopidine on saphenous vein bypass patency rates: a double-blind study. Ann. Thorac. Surg. 37, 371\u2013378 (1984).","journal-title":"Ann. Thorac. Surg."},{"key":"BFnrcardio201676_CR212","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0022-5223(19)36194-X","volume":"94","author":"R Limet","year":"1987","unstructured":"Limet, R., David, J. L., Magotteaux, P., Larock, M. P. & Rigo, P. Prevention of aorta-coronary bypass graft occlusion. Beneficial effect of ticlopidine on early and late patency rates of venous coronary bypass grafts: a double-blind study. J. Thorac. Cardiovasc. Surg. 94, 773\u2013783 (1987).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"BFnrcardio201676_CR213","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1056\/NEJM199712113372404","volume":"337","author":"JP Becquemin","year":"1997","unstructured":"Becquemin, J. P. Effect of ticlopidine on the long-term patency of saphenous-vein bypass grafts in the legs. Etude de la Ticlopidine apr\u00e8s Pontage F\u00e9moro-Poplit\u00e9 and the Association Universitaire de Recherche en Chirurgie. N. Engl. J. Med. 337, 1726\u20131731 (1997).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201676_CR214","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1161\/01.CIR.100.15.1667","volume":"100","author":"MJ Quinn","year":"1999","unstructured":"Quinn, M. J. & Fitzgerald, D. J. Ticlopidine and clopidogrel. Circulation 100, 1667\u20131672 (1999).","journal-title":"Circulation"},{"key":"BFnrcardio201676_CR215","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3400\/avd.oa.12.00039","volume":"5","author":"H Shigematsu","year":"2012","unstructured":"Shigematsu, H., Komori, K., Tanemoto, K., Harada, Y. & Nakamura, M. Clopidogrel for Atherothrombotic Event Management in Patients with Peripheral Arterial Disease (COOPER) Study: safety and efficacy of clopidogrel versus ticlopidine in Japanese patients. Ann. Vasc. Dis. 5, 364\u2013375 (2012).","journal-title":"Ann. Vasc. Dis."},{"key":"BFnrcardio201676_CR216","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jvs.2010.04.027","volume":"52","author":"JJ Belch","year":"2010","unstructured":"Belch, J. J. et al. Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial. J. Vasc. Surg. 52, 825\u2013833.e2 (2010).","journal-title":"J. Vasc. Surg."},{"key":"BFnrcardio201676_CR217","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/jocs.12074","volume":"28","author":"SV Deo","year":"2013","unstructured":"Deo, S. V. et al. Dual anti-platelet therapy after coronary artery bypass grafting: is there any benefit? A systematic review and meta-analysis. J. Card. Surg. 28, 109\u2013116 (2013).","journal-title":"J. Card. Surg."},{"key":"BFnrcardio201676_CR218","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/imi.0b013e3181bbc754","volume":"4","author":"E Mujanovic","year":"2009","unstructured":"Mujanovic, E. et al. The effect of combined clopidogrel and aspirin therapy after off-pump coronary surgery: a pilot study. Innovations (Phila.) 4, 265\u2013268 (2009).","journal-title":"Innovations (Phila.)"},{"key":"BFnrcardio201676_CR219","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.jacc.2010.03.104","volume":"56","author":"G Gao","year":"2010","unstructured":"Gao, G. et al. Aspirin plus clopidogrel therapy increases early venous graft patency after coronary artery bypass surgery a single-center, randomized, controlled trial. J. Am. Coll. Cardiol. 56, 1639\u20131643 (2010).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201676_CR220","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.ahj.2010.07.035","volume":"160","author":"JC Sun","year":"2010","unstructured":"Sun, J. C. et al. Randomized trial of aspirin and clopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: the Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting study. Am. Heart J. 160, 1178\u20131184 (2010).","journal-title":"Am. Heart J."},{"key":"BFnrcardio201676_CR221","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0140-6736(93)91815-4","volume":"342","author":"J van der Meer","year":"1993","unstructured":"van der Meer, J. et al. Prevention of one-year vein-graft occlusion after aortocoronary-bypass surgery: a comparison of low-dose aspirin, low-dose aspirin plus dipyridamole, and oral anticoagulants. The CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands. Lancet 342, 257\u2013264 (1993).","journal-title":"Lancet"},{"key":"BFnrcardio201676_CR222","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/1010-7940(93)90155-5","volume":"7","author":"SE Fremes","year":"1993","unstructured":"Fremes, S. E. et al. Optimal antithrombotic therapy following aortocoronary bypass: a meta-analysis. Eur. J. Cardiothorac. Surg. 7, 169\u2013180 (1993).","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"BFnrcardio201676_CR223","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1136\/bmj.327.7427.1309","volume":"327","author":"E Lim","year":"2003","unstructured":"Lim, E. et al. Indirect comparison meta-analysis of aspirin therapy after coronary surgery. BMJ 327, 1309 (2003).","journal-title":"BMJ"},{"key":"BFnrcardio201676_CR224","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1067\/mva.2002.121847","volume":"35","author":"WC Johnson","year":"2002","unstructured":"Johnson, W. C. & Williford, W. O. Benefits, morbidity, and mortality associated with long-term administration of oral anticoagulant therapy to patients with peripheral arterial bypass procedures: a prospective randomized study. J. Vasc. Surg. 35, 413\u2013421 (2002).","journal-title":"J. Vasc. Surg."},{"key":"BFnrcardio201676_CR225","first-page":"CD000535","volume":"2","author":"R Bedenis","year":"2015","unstructured":"Bedenis, R., Lethaby, A., Maxwell, H., Acosta, S. & Prins, M. H. Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery. Cochrane Database Syst. Rev. 2, CD000535 (2015).","journal-title":"Cochrane Database Syst. Rev."},{"key":"BFnrcardio201676_CR226","first-page":"105","volume":"27","author":"JY Lee","year":"2016","unstructured":"Lee, J. Y., Sung, K. C. & Choi, H. I. Comparison of aspirin and indobufen in healthy volunteers. Platelets 27, 105\u2013109 (2016).","journal-title":"Platelets"},{"key":"BFnrcardio201676_CR227","first-page":"106","volume":"11","author":"M D'Addato","year":"1992","unstructured":"D'Addato, M. et al. Indobufen versus acetylsalicylic acid plus dipyridamole in long-term patency after femoropopliteal bypass. Int. Angiol. 11, 106\u2013112 (1992).","journal-title":"Int. Angiol."},{"key":"BFnrcardio201676_CR228","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S0022-5223(94)70392-2","volume":"107","author":"SM Rajah","year":"1994","unstructured":"Rajah, S. M. et al. Effects of antiplatelet therapy with indobufen or aspirin-dipyridamole on graft patency one year after coronary artery bypass grafting. J. Thorac. Cardiovasc. Surg. 107, 1146\u20131153 (1994).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"BFnrcardio201676_CR229","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/00019501-199809040-00007","volume":"9","author":"G Cataldo","year":"1998","unstructured":"Cataldo, G., Heiman, F., Lavezzari, M. & Marubini, E. Indobufen compared with aspirin and dipyridamole on graft patency after coronary artery bypass surgery: results of a combined analysis. Coron. Artery Dis. 9, 217\u2013222 (1998).","journal-title":"Coron. Artery Dis."},{"key":"BFnrcardio201676_CR230","first-page":"CD000536","volume":"6","author":"AJ Geraghty","year":"2011","unstructured":"Geraghty, A. J. & Welch, K. Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery. Cochrane Database Syst. Rev. 6, CD000536 (2011).","journal-title":"Cochrane Database Syst. Rev."},{"key":"BFnrcardio201676_CR231","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/EJA.0000000000000340","volume":"33","author":"S Venkatesan","year":"2016","unstructured":"Venkatesan, S. et al. Effects of five preoperative cardiovascular drugs on mortality after coronary artery bypass surgery: a retrospective analysis of an observational study of 16,192 patients. Eur. J. Anaesthesiol. 33, 49\u201357 (2016).","journal-title":"Eur. J. Anaesthesiol."},{"key":"BFnrcardio201676_CR232","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/S0140-6736(05)72267-4","volume":"355","author":"A Algra","year":"2000","unstructured":"Algra, A., Tangelder, M. J., Lawson, J. A. & Eikelboom, B. C. Interpretation of Dutch BOA trial. Dutch Bypass Oral anticoagulants or Aspirin study group. Lancet 355, 1186\u20131187 (2000).","journal-title":"Lancet"},{"key":"BFnrcardio201676_CR233","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0005-2760(96)00184-1","volume":"1345","author":"P Negre-Aminou","year":"1997","unstructured":"Negre-Aminou, P. et al. Inhibition of proliferation of human smooth muscle cells by various HMG-CoA reductase inhibitors; comparison with other human cell types. Biochim. Biophys. Acta 1345, 259\u2013268 (1997).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnrcardio201676_CR234","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1016\/S0735-1097(98)00487-2","volume":"32","author":"C Bustos","year":"1998","unstructured":"Bustos, C. et al. HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis. J. Am. Coll. Cardiol. 32, 2057\u20132064 (1998).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201676_CR235","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0735-1097(99)00526-4","volume":"35","author":"C Indolfi","year":"2000","unstructured":"Indolfi, C. et al. Effects of hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin on smooth muscle cell proliferation in vitro and neointimal formation in vivo after vascular injury. J. Am. Coll. Cardiol. 35, 214\u2013221 (2000).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201676_CR236","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ejvs.2004.11.003","volume":"29","author":"JM Corpataux","year":"2005","unstructured":"Corpataux, J. M., Naik, J., Porter, K. E. & London, N. J. A comparison of six statins on the development of intimal hyperplasia in a human vein culture model. Eur. J. Vasc. Endovasc. Surg. 29, 177\u2013181 (2005).","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"BFnrcardio201676_CR237","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1161\/CIRCULATIONAHA.108.799445","volume":"118","author":"A Kulik","year":"2008","unstructured":"Kulik, A. et al. Impact of statin use on outcomes after coronary artery bypass graft surgery. Circulation 118, 1785\u20131792 (2008).","journal-title":"Circulation"},{"key":"BFnrcardio201676_CR238","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/1749-8090-8-172","volume":"8","author":"K Jerzewski","year":"2013","unstructured":"Jerzewski, K., Ruel, M., Voisine, P., Le May, M. R. & Kulik, A. Does high-density lipoprotein influence the development of saphenous vein graft disease after coronary bypass surgery?: exploratory analysis from the CASCADE trial. J. Cardiothorac. Surg. 8, 172 (2013).","journal-title":"J. Cardiothorac. Surg."},{"key":"BFnrcardio201676_CR239","doi-asserted-by":"crossref","first-page":"912","DOI":"10.4330\/wjc.v7.i12.912","volume":"7","author":"S Spiliopoulos","year":"2015","unstructured":"Spiliopoulos, S. & Pastromas, G. Current status of high on-treatment platelet reactivity in patients with coronary or peripheral arterial disease: mechanisms, evaluation and clinical implications. World J. Cardiol. 7, 912\u2013921 (2015).","journal-title":"World J. Cardiol."},{"key":"BFnrcardio201676_CR240","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/eurheartj\/ehv381","volume":"37","author":"EC Hansson","year":"2016","unstructured":"Hansson, E. C. et al. Coronary artery bypass grafting-related bleeding complications in patients treated with ticagrelor or clopidogrel: a nationwide study. Eur. Heart J. 37, 189\u2013197 (2016).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio201676_CR241","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1007\/s00270-014-0852-y","volume":"37","author":"S Spiliopoulos","year":"2014","unstructured":"Spiliopoulos, S. et al. Initial experience with ticagrelor in patients with critical limb ischemia and high on-clopidogrel platelet reactivity undergoing complex peripheral endovascular procedures. Cardiovasc. Intervent. Radiol. 37, 1450\u20131457 (2014).","journal-title":"Cardiovasc. Intervent. Radiol."},{"key":"BFnrcardio201676_CR242","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/00325481.2016.1118351","volume":"128","author":"F Amico","year":"2016","unstructured":"Amico, F., Amico, A., Mazzoni, J., Moshiyakhov, M. & Tamparo, W. The evolution of dual antiplatelet therapy in the setting of acute coronary syndrome: ticagrelor versus clopidogrel. Postgrad. Med. 128, 159\u2013163 (2016).","journal-title":"Postgrad. Med."},{"key":"BFnrcardio201676_CR243","unstructured":"US National Library of Science. ClinicalTrials.gov http:\/\/clinicaltrials.gov\/show\/NCT01755520 (2016)."},{"key":"BFnrcardio201676_CR244","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.2165\/11538060-000000000-00000","volume":"70","author":"S Leonardi","year":"2010","unstructured":"Leonardi, S., Tricoci, P. & Becker, R. C. Thrombin receptor antagonists for the treatment of atherothrombosis: therapeutic potential of vorapaxar and E-5555. Drugs 70, 1771\u20131783 (2010).","journal-title":"Drugs"},{"key":"BFnrcardio201676_CR245","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s12265-013-9454-3","volume":"6","author":"BF de Souza","year":"2013","unstructured":"de Souza, B. F. & Tricoci, P. Novel anti-platelet agents: focus on thrombin receptor antagonists. J. Cardiovasc. Transl. Res. 6, 415\u2013424 (2013).","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"BFnrcardio201676_CR246","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0140-6736(09)60230-0","volume":"373","author":"RC Becker","year":"2009","unstructured":"Becker, R. C. et al. Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II study. Lancet 373, 919\u2013928 (2009).","journal-title":"Lancet"},{"key":"BFnrcardio201676_CR247","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1056\/NEJMoa1200933","volume":"366","author":"DA Morrow","year":"2012","unstructured":"Morrow, D. A. et al. Vorapaxar in the secondary prevention of atherothrombotic events. N. Engl. J. Med. 366, 1404\u20131413 (2012).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201676_CR248","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1161\/CIRCULATIONAHA.114.015042","volume":"132","author":"EA Bohula","year":"2015","unstructured":"Bohula, E. A. et al. Efficacy and safety of vorapaxar with and without a thienopyridine for secondary prevention in patients with previous myocardial infarction and no history of stroke or transient ischemic attack. Circulation 132, 1871\u20131879 (2015).","journal-title":"Circulation"},{"key":"BFnrcardio201676_CR249","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jacc.2013.10.048","volume":"63","author":"DJ Whellan","year":"2014","unstructured":"Whellan, D. J. et al. Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery: subgroup analysis from the TRACER trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome). J. Am. Coll. Cardiol. 63, 1048\u20131057 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201676_CR250","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1093\/eurheartj\/ehq320","volume":"31","author":"S Goto","year":"2010","unstructured":"Goto, S., Ogawa, H., Takeuchi, M., Flather, M. D. & Bhatt, D. L. Double-blind, placebo-controlled Phase II studies of the protease-activated receptor 1 antagonist E5555 (atopaxar) in Japanese patients with acute coronary syndrome or high-risk coronary artery disease. Eur. Heart J. 31, 2601\u20132613 (2010).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio201676_CR251","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ejphar.2011.05.034","volume":"666","author":"M Kogushi","year":"2011","unstructured":"Kogushi, M. et al. Oral administration of the thrombin receptor antagonist E5555 (atopaxar) attenuates intimal thickening following balloon injury in rats. Eur. J. Pharmacol. 666, 158\u2013164 (2011).","journal-title":"Eur. J. Pharmacol."},{"key":"BFnrcardio201676_CR252","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.jvs.2012.11.040","volume":"57","author":"MS Conte","year":"2013","unstructured":"Conte, M. S. et al. A single nucleotide polymorphism in the p27Kip1 gene is associated with primary patency of lower extremity vein bypass grafts. J. Vasc. Surg. 57, 1179\u20131185 (2013).","journal-title":"J. Vasc. Surg."},{"key":"BFnrcardio201676_CR253","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1161\/CIRCULATIONAHA.110.000786","volume":"123","author":"ML O'Donoghue","year":"2011","unstructured":"O'Donoghue, M. L. et al. Safety and tolerability of atopaxar in the treatment of patients with acute coronary syndromes: the lessons from antagonizing the cellular effects of Thrombin-Acute Coronary Syndromes Trial. Circulation 123, 1843\u20131853 (2011).","journal-title":"Circulation"},{"key":"BFnrcardio201676_CR254","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1161\/CIRCULATIONAHA.110.001404","volume":"123","author":"SD Wiviott","year":"2011","unstructured":"Wiviott, S. D. et al. Randomized trial of atopaxar in the treatment of patients with coronary artery disease: the lessons from antagonizing the cellular effect of Thrombin-Coronary Artery Disease Trial. Circulation 123, 1854\u20131863 (2011).","journal-title":"Circulation"},{"key":"BFnrcardio201676_CR255","first-page":"e75","volume":"15","author":"SF Louis","year":"2010","unstructured":"Louis, S. F. & Zahradka, P. Vascular smooth muscle cell motility: from migration to invasion. Exp. Clin. Cardiol. 15, e75\u2013e85 (2010).","journal-title":"Exp. Clin. Cardiol."},{"key":"BFnrcardio201676_CR256","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0828-282X(07)70886-3","volume":"23","author":"AW Chung","year":"2007","unstructured":"Chung, A. W. et al. Arterialization of a vein graft promotes cell cycle progression through Akt and p38 mitogen-activated protein kinase pathways: impact of the preparation procedure. Can. J. Cardiol. 23, 1147\u20131154 (2007).","journal-title":"Can. J. Cardiol."},{"key":"BFnrcardio201676_CR257","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1161\/CIRCRESAHA.110.222588","volume":"107","author":"J Cheng","year":"2010","unstructured":"Cheng, J. et al. The mechanical stress-activated serum-, glucocorticoid-regulated kinase 1 contributes to neointima formation in vein grafts. Circ. Res. 107, 1265\u20131274 (2010).","journal-title":"Circ. Res."},{"key":"BFnrcardio201676_CR258","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.cardiores.2006.11.015","volume":"73","author":"GJ Murphy","year":"2007","unstructured":"Murphy, G. J. et al. Short- and long-term effects of cytochalasin D, paclitaxel and rapamycin on wall thickening in experimental porcine vein grafts. Cardiovasc. Res. 73, 607\u2013617 (2007).","journal-title":"Cardiovasc. Res."},{"key":"BFnrcardio201676_CR259","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1016\/j.transproceed.2010.12.063","volume":"43","author":"HL Chen","year":"2011","unstructured":"Chen, H. L., Liu, K., Meng, X. Y., Wen, X. D. & You, Q. S. Local application of rapamycin inhibits vein graft restenosis in rabbits. Transplant. Proc. 43, 2017\u20132021 (2011).","journal-title":"Transplant. Proc."},{"key":"BFnrcardio201676_CR260","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1161\/CIRCINTERVENTIONS.109.864660","volume":"3","author":"T Rajathurai","year":"2010","unstructured":"Rajathurai, T. et al. Periadventitial rapamycin-eluting microbeads promote vein graft disease in long-term pig vein-into-artery interposition grafts. Circ. Cardiovasc. Interv. 3, 157\u2013165 (2010).","journal-title":"Circ. Cardiovasc. Interv."},{"key":"BFnrcardio201676_CR261","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1067\/mtc.2001.111204","volume":"121","author":"A Ehsan","year":"2001","unstructured":"Ehsan, A., Mann, M. J., Dell'Acqua, G. & Dzau, V. J. Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide gene therapy. J. Thorac. Cardiovasc. Surg. 121, 714\u2013722 (2001).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"BFnrcardio201676_CR262","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/S0140-6736(99)09405-2","volume":"354","author":"MJ Mann","year":"1999","unstructured":"Mann, M. J. et al. Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial. Lancet 354, 1493\u20131498 (1999).","journal-title":"Lancet"},{"key":"BFnrcardio201676_CR263","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1001\/jamasurg.2014.87","volume":"149","author":"RE Harskamp","year":"2014","unstructured":"Harskamp, R. E. et al. Vein graft preservation solutions, patency, and outcomes after coronary artery bypass graft surgery: follow-up from the PREVENT IV randomized clinical trial. JAMA Surg. 149, 798\u2013805 (2014).","journal-title":"JAMA Surg."},{"key":"BFnrcardio201676_CR264","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/153857440503900102","volume":"39","author":"MS Conte","year":"2005","unstructured":"Conte, M. S. et al. Design and rationale of the PREVENT III clinical trial: edifoligide for the prevention of infrainguinal vein graft failure. Vasc. Endovasc. Surg. 39, 15\u201323 (2005).","journal-title":"Vasc. Endovasc. Surg."},{"key":"BFnrcardio201676_CR265","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.trsl.2012.12.003","volume":"161","author":"KW Southerland","year":"2013","unstructured":"Southerland, K. W., Frazier, S. B., Bowles, D. E., Milano, C. A. & Kontos, C. D. Gene therapy for the prevention of vein graft disease. Transl. Res. 161, 321\u2013338 (2013).","journal-title":"Transl. Res."},{"key":"BFnrcardio201676_CR266","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/jocs.12075","volume":"28","author":"XW Wang","year":"2013","unstructured":"Wang, X. W., Zhao, X. J. & Xiang, X. Y. Gene therapy for vein graft failure. J. Card. Surg. 28, 144\u2013147 (2013).","journal-title":"J. Card. Surg."},{"key":"BFnrcardio201676_CR267","first-page":"125","volume":"18","author":"L Pradhan-Nabzdyk","year":"2014","unstructured":"Pradhan-Nabzdyk, L., Huang, C., LoGerfo, F. W. & Nabzdyk, C. S. Current siRNA targets in the prevention and treatment of intimal hyperplasia. Discov. Med. 18, 125\u2013132 (2014).","journal-title":"Discov. Med."},{"key":"BFnrcardio201676_CR268","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/j.athoracsur.2015.01.060","volume":"99","author":"DP Taggart","year":"2015","unstructured":"Taggart, D. P. et al. A randomized trial of external stenting for saphenous vein grafts in coronary artery bypass grafting. Ann. Thorac. Surg. 99, 2039\u20132045 (2015).","journal-title":"Ann. Thorac. Surg."},{"key":"BFnrcardio201676_CR269","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jtcvs.2007.01.092","volume":"134","author":"GJ Murphy","year":"2007","unstructured":"Murphy, G. J., Newby, A. C., Jeremy, J. Y., Baumbach, A. & Angelini, G. D. A randomized trial of an external Dacron sheath for the prevention of vein graft disease: the Extent study. J. Thorac. Cardiovasc. Surg. 134, 504\u2013505 (2007).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"BFnrcardio201676_CR270","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1510\/icvts.2010.265116","volume":"13","author":"J Schoettler","year":"2011","unstructured":"Schoettler, J. et al. Highly flexible nitinol mesh to encase aortocoronary saphenous vein grafts: first clinical experiences and angiographic results nine months postoperatively. Interact. Cardiovasc. Thorac. Surg. 13, 396\u2013400 (2011).","journal-title":"Interact. Cardiovasc. Thorac. Surg."},{"key":"BFnrcardio201676_CR271","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/MAT.0000000000000187","volume":"61","author":"RW Emery","year":"2015","unstructured":"Emery, R. W., Solien, E. & Klima, U. Clinical evaluation of the eSVS Mesh: First-in-Man trial outcomes. ASAIO J. 61, 178\u2013183 (2015).","journal-title":"ASAIO J."},{"key":"BFnrcardio201676_CR272","doi-asserted-by":"publisher","unstructured":"Ferrari, E., von, S. L. & Berdajs, D. Improving coronary artery bypass graft durability: use of the external saphenous vein graft support. Multimed. Man. Cardiothorac. Surg. http:\/\/dx.doi.org\/10.1093\/mmcts\/mmv005 (2015).","DOI":"10.1093\/mmcts\/mmv005"},{"key":"BFnrcardio201676_CR273","unstructured":"US National Library of Science. ClinicalTrials.gov http:\/\/clinicaltrials.gov\/show\/NCT02072239 (2015)."},{"key":"BFnrcardio201676_CR274","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0022-5223(19)40363-2","volume":"70","author":"M Riahi","year":"1975","unstructured":"Riahi, M., Vasu, C. M., Tomatis, L. A., Schlosser, R. J. & Zimmerman, G. Aneurysm of saphenous vein bypass graft to coronary artery. J. Thorac. Cardiovasc. Surg. 70, 358\u2013359 (1975).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"BFnrcardio201676_CR275","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00045415-200301000-00006","volume":"11","author":"AQ Memon","year":"2003","unstructured":"Memon, A. Q., Huang, R. I., Marcus, F., Xavier, L. & Alpert, J. Saphenous vein graft aneurysm: case report and review. Cardiol. Rev. 11, 26\u201334 (2003).","journal-title":"Cardiol. Rev."},{"key":"BFnrcardio201676_CR276","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1161\/CIRCULATIONAHA.112.101592","volume":"126","author":"FD Ramirez","year":"2012","unstructured":"Ramirez, F. D. et al. Natural history and management of aortocoronary saphenous vein graft aneurysms: a systematic review of published cases. Circulation 126, 2248\u20132256 (2012).","journal-title":"Circulation"},{"key":"BFnrcardio201676_CR277","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.jvs.2007.07.049","volume":"46","author":"SA Berceli","year":"2007","unstructured":"Berceli, S. A. et al. Surgical and endovascular revision of infrainguinal vein bypass grafts: analysis of midterm outcomes from the PREVENT III trial. J. Vasc. Surg. 46, 1173\u20131179 (2007).","journal-title":"J. Vasc. Surg."},{"key":"BFnrcardio201676_CR278","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/j.athoracsur.2005.04.033","volume":"80","author":"JF Sabik","year":"2005","unstructured":"Sabik, J. F. et al. Is reoperation still a risk factor in coronary artery bypass surgery? Ann. Thorac. Surg. 80, 1719\u20131727 (2005).","journal-title":"Ann. Thorac. Surg."},{"key":"BFnrcardio201676_CR279","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.athoracsur.2009.02.006","volume":"87","author":"CH Yap","year":"2009","unstructured":"Yap, C. H. et al. Contemporary results show repeat coronary artery bypass grafting remains a risk factor for operative mortality. Ann. Thorac. Surg. 87, 1386\u20131391 (2009).","journal-title":"Ann. Thorac. Surg."},{"key":"BFnrcardio201676_CR280","first-page":"64","volume":"24","author":"V Hindnavis","year":"2012","unstructured":"Hindnavis, V., Cho, S. H. & Goldberg, S. Saphenous vein graft intervention: a review. J. Invasive Cardiol. 24, 64\u201371 (2012).","journal-title":"J. Invasive Cardiol."},{"key":"BFnrcardio201676_CR281","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/1538574409336479","volume":"43","author":"JA Eisenberg","year":"2009","unstructured":"Eisenberg, J. A. et al. Is balloon angioplasty of peri-anastomotic stenoses of failing peripheral arterial bypasses worthwhile? Vasc. Endovascular Surg. 43, 346\u2013351 (2009).","journal-title":"Vasc. Endovascular Surg."},{"key":"BFnrcardio201676_CR282","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1161\/01.CIR.0000012783.63093.0C","volume":"105","author":"DS Baim","year":"2002","unstructured":"Baim, D. S. et al. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation 105, 1285\u20131290 (2002).","journal-title":"Circulation"},{"key":"BFnrcardio201676_CR283","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.amjcard.2007.04.058","volume":"100","author":"SK Mehta","year":"2007","unstructured":"Mehta, S. K. et al. Utilization of distal embolic protection in saphenous vein graft interventions (an analysis of 19,546 patients in the American College of Cardiology-National Cardiovascular Data Registry). Am. J. Cardiol. 100, 1114\u20131118 (2007).","journal-title":"Am. J. Cardiol."},{"key":"BFnrcardio201676_CR284","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nrcardio.2011.148","volume":"9","author":"JW Jukema","year":"2012","unstructured":"Jukema, J. W., Ahmed, T. A., Verschuren, J. J. & Quax, P. H. Restenosis after PCI. Part 2: prevention and therapy. Nat. Rev. Cardiol. 9, 79\u201390 (2012).","journal-title":"Nat. Rev. Cardiol."},{"key":"BFnrcardio201676_CR285","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1056\/NEJM199709113371103","volume":"337","author":"MP Savage","year":"1997","unstructured":"Savage, M. P. et al. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. N. Engl. J. Med. 337, 740\u2013747 (1997).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201676_CR286","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.3892\/etm.2015.2366","volume":"9","author":"Y Liu","year":"2015","unstructured":"Liu, Y. et al. Percutaneous coronary intervention strategies and prognosis for graft lesions following coronary artery bypass grafting. Exp. Ther. Med. 9, 1656\u20131664 (2015).","journal-title":"Exp. Ther. Med."},{"key":"BFnrcardio201676_CR287","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jvs.2015.01.052","volume":"62","author":"H Ali","year":"2015","unstructured":"Ali, H., Elbadawy, A., Saleh, M. & Hasaballah, A. Balloon angioplasty for revision of failing lower extremity bypass grafts. J. Vasc. Surg. 62, 93\u2013100 (2015).","journal-title":"J. Vasc. Surg."},{"key":"BFnrcardio201676_CR288","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1583\/13-4473R.1","volume":"21","author":"EM San Norberto","year":"2014","unstructured":"San Norberto, E. M., Taylor, J. H., Carrera, S. & Vaquero, C. Percutaneous transluminal angioplasty with drug-eluting balloons for salvage of infrainguinal bypass grafts. J. Endovasc. Ther. 21, 12\u201321 (2014).","journal-title":"J. Endovasc. Ther."},{"issue":"1","key":"BFnrcardio201676_CR289","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/ccd.25979","volume":"87","author":"J. Matthew Brennan","year":"2015","unstructured":"Brennan, J. M. et al. Safety and clinical effectiveness of drug-eluting stents for saphenous vein graft intervention in older individuals: results from the medicare-linked National Cardiovascular Data Registry CathPCI Registry\u00ae (2005\u20132009). Catheter. Cardiovasc. Interv. http:\/\/dx.doi.org\/10.1002\/ccd.25979 (2015).","journal-title":"Catheterization and Cardiovascular Interventions"},{"key":"BFnrcardio201676_CR290","doi-asserted-by":"crossref","first-page":"E204","DOI":"10.1002\/term.1798","volume":"10","author":"M Piola","year":"2016","unstructured":"Piola, M. et al. A compact and automated ex vivo vessel culture system for the pulsatile pressure conditioning of human saphenous veins. J. Tissue Eng. Regen. Med. 10, E204\u2013E215 (2016).","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"BFnrcardio201676_CR291","doi-asserted-by":"crossref","first-page":"I302","DOI":"10.1161\/CIRCULATIONAHA.105.001339","volume":"114","author":"SP Salzberg","year":"2006","unstructured":"Salzberg, S. P. et al. Increased neointimal formation after surgical vein grafting in a murine model of type 2 diabetes. Circulation 114, I302\u2013I307 (2006).","journal-title":"Circulation"},{"key":"BFnrcardio201676_CR292","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1161\/CIRCULATIONAHA.105.536268","volume":"112","author":"PS Monraats","year":"2005","unstructured":"Monraats, P. S. et al. Genetic inflammatory factors predict restenosis after percutaneous coronary interventions. Circulation 112, 2417\u20132425 (2005).","journal-title":"Circulation"},{"key":"BFnrcardio201676_CR293","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s10439-008-9495-y","volume":"36","author":"R Tran-Son-Tay","year":"2008","unstructured":"Tran-Son-Tay, R. et al. An experiment-based model of vein graft remodeling induced by shear stress. Ann. Biomed. Eng. 36, 1083\u20131091 (2008).","journal-title":"Ann. Biomed. Eng."},{"key":"BFnrcardio201676_CR294","doi-asserted-by":"crossref","first-page":"e57822","DOI":"10.1371\/journal.pone.0057822","volume":"8","author":"M Hwang","year":"2013","unstructured":"Hwang, M. et al. Rule-based model of vein graft remodeling. PLoS ONE 8, e57822 (2013).","journal-title":"PLoS ONE"},{"key":"BFnrcardio201676_CR295","doi-asserted-by":"publisher","unstructured":"Webb, C. M., Orion, E., Taggart, D. P., Channon, K. M. & Di, M. C. OCT imaging of aorto-coronary vein graft pathology modified by external stenting: 1-year post-surgery. Eur. Heart J. Cardiovasc. Imaging http:\/\/dx.doi.org\/10.1093\/ehjci\/jev310 (2015).","DOI":"10.1093\/ehjci\/jev310"},{"key":"BFnrcardio201676_CR296","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0022-5223(94)70320-5","volume":"107","author":"MJ Boylan","year":"1994","unstructured":"Boylan, M. J. et al. Surgical treatment of isolated left anterior descending coronary stenosis. Comparison of left internal mammary artery and venous autograft at 18 to 20 years of follow-up. J. Thorac. Cardiovasc. Surg. 107, 657\u2013662 (1994).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"BFnrcardio201676_CR297","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jtcvs.2005.05.024","volume":"131","author":"JF Sabik","year":"2006","unstructured":"Sabik, J. F. et al. Influence of patient characteristics and arterial grafts on freedom from coronary reoperation. J. Thorac. Cardiovasc. Surg. 131, 90\u201398 (2006).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"BFnrcardio201676_CR298","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.athoracsur.2009.03.086","volume":"88","author":"J Tatoulis","year":"2009","unstructured":"Tatoulis, J. et al. Long-term patency of 1108 radial arterial-coronary angiograms over 10 years. Ann. Thorac. Surg. 88, 23\u201329 (2009).","journal-title":"Ann. Thorac. Surg."},{"key":"BFnrcardio201676_CR299","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jtcvs.2009.05.038","volume":"139","author":"U Benedetto","year":"2010","unstructured":"Benedetto, U., Angeloni, E., Refice, S. & Sinatra, R. Radial artery versus saphenous vein graft patency: meta-analysis of randomized controlled trials. J. Thorac. Cardiovasc. Surg. 139, 229\u2013231 (2010).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"BFnrcardio201676_CR300","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/jama.2010.1976","volume":"305","author":"S Goldman","year":"2011","unstructured":"Goldman, S. et al. Radial artery grafts versus saphenous vein grafts in coronary artery bypass surgery: a randomized trial. JAMA 305, 167\u2013174 (2011).","journal-title":"JAMA"},{"key":"BFnrcardio201676_CR301","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13019-015-0331-9","volume":"10","author":"I Petrovic","year":"2015","unstructured":"Petrovic, I. et al. Radial artery versus saphenous vein graft used as the second conduit for surgical myocardial revascularization: long-term clinical follow-up. J. Cardiothorac. Surg. 10, 127 (2015).","journal-title":"J. Cardiothorac. Surg."},{"key":"BFnrcardio201676_CR302","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1161\/CIRCRESAHA.115.306403","volume":"116","author":"JP Cooke","year":"2015","unstructured":"Cooke, J. P. & Chen, Z. A compendium on peripheral arterial disease. Circ. Res. 116, 1505\u20131508 (2015).","journal-title":"Circ. Res."},{"key":"BFnrcardio201676_CR303","first-page":"33","volume":"80","author":"ME O'Donnell","year":"2011","unstructured":"O'Donnell, M. E., Reid, J. A., Lau, L. L., Hannon, R. J. & Lee, B. Optimal management of peripheral arterial disease for the non-specialist. Ulster Med. J. 80, 33\u201341 (2011).","journal-title":"Ulster Med. J."},{"key":"BFnrcardio201676_CR304","doi-asserted-by":"crossref","first-page":"E581","DOI":"10.1532\/HSF98.20061034","volume":"9","author":"K Ibrahim","year":"2006","unstructured":"Ibrahim, K. et al. Effect of clopidogrel on midterm graft patency following off-pump coronary revascularization surgery. Heart Surg. Forum 9, E581\u2013E856 (2006).","journal-title":"Heart Surg. Forum"},{"key":"BFnrcardio201676_CR305","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1517\/14740330902797081","volume":"8","author":"A Kulik","year":"2009","unstructured":"Kulik, A., Chan, V. & Ruel, M. Antiplatelet therapy and coronary artery bypass graft surgery: perioperative safety and efficacy. Expert Opin. Drug Saf. 8, 169\u2013182 (2009).","journal-title":"Expert Opin. Drug Saf."},{"key":"BFnrcardio201676_CR306","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.athoracsur.2013.08.058","volume":"97","author":"R Ebrahimi","year":"2014","unstructured":"Ebrahimi, R. et al. Effect of clopidogrel use post coronary artery bypass surgery on graft patency. Ann. Thorac. Surg. 97, 15\u201321 (2014).","journal-title":"Ann. Thorac. Surg."},{"key":"BFnrcardio201676_CR307","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.athoracsur.2009.04.024","volume":"88","author":"C Gao","year":"2009","unstructured":"Gao, C., Ren, C., Li, D. & Li, L. Clopidogrel and aspirin versus clopidogrel alone on graft patency after coronary artery bypass grafting. Ann. Thorac. Surg. 88, 59\u201362 (2009).","journal-title":"Ann. Thorac. Surg."},{"key":"BFnrcardio201676_CR308","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1136\/heartjnl-2012-302449","volume":"98","author":"VA Mannacio","year":"2012","unstructured":"Mannacio, V. A. et al. Aspirin plus clopidogrel for optimal platelet inhibition following off-pump coronary artery bypass surgery: results from the CRYSSA (prevention of Coronary arteRY bypaSS occlusion After off-pump procedures) randomised study. Heart 98, 1710\u20131715 (2012).","journal-title":"Heart"},{"key":"BFnrcardio201676_CR309","first-page":"462","volume":"96","author":"TR Kohler","year":"1984","unstructured":"Kohler, T. R. et al. Effect of aspirin and dipyridamole on the patency of lower extremity bypass grafts. Surgery 96, 462\u2013466 (1984).","journal-title":"Surgery"},{"key":"BFnrcardio201676_CR310","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1177\/000331978503600904","volume":"36","author":"B Satiani","year":"1985","unstructured":"Satiani, B. A prospective randomized trial of aspirin in femoral popliteal and tibial bypass grafts. Angiology 36, 608\u2013616 (1985).","journal-title":"Angiology"},{"key":"BFnrcardio201676_CR311","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/bjs.1800740406","volume":"74","author":"CA Clyne","year":"1987","unstructured":"Clyne, C. A., Archer, T. J., Atuhaire, L. K., Chant, A. D. & Webster, J. H. Random control trial of a short course of aspirin and dipyridamole (Persantin) for femorodistal grafts. Br. J. Surg. 74, 246\u2013248 (1987).","journal-title":"Br. J. Surg."},{"key":"BFnrcardio201676_CR312","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/0741-5214(91)90022-M","volume":"13","author":"C McCollum","year":"1991","unstructured":"McCollum, C., Alexander, C., Kenchington, G., Franks, P. J. & Greenhalgh, R. Antiplatelet drugs in femoropopliteal vein bypasses: a multicenter trial. J. Vasc. Surg. 13, 150\u2013161 (1991).","journal-title":"J. Vasc. Surg."},{"key":"BFnrcardio201676_CR313","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0140-6736(94)92269-1","volume":"344","author":"RA Edmondson","year":"1994","unstructured":"Edmondson, R. A., Cohen, A. T., Das, S. K., Wagner, M. B. & Kakkar, V. V. Low-molecular weight heparin versus aspirin and dipyridamole after femoropopliteal bypass grafting. Lancet 344, 914\u2013918 (1994).","journal-title":"Lancet"},{"key":"BFnrcardio201676_CR314","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jvs.2012.01.004","volume":"56","author":"M Monaco","year":"2012","unstructured":"Monaco, M. et al. Combination therapy with warfarin plus clopidogrel improves outcomes in femoropopliteal bypass surgery patients. J. Vasc. Surg. 56, 96\u2013105 (2012).","journal-title":"J. Vasc. Surg."}],"container-title":["Nature Reviews Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrcardio.2016.76.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrcardio.2016.76","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrcardio.2016.76.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T23:59:16Z","timestamp":1684454356000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrcardio.2016.76"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,19]]},"references-count":314,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["BFnrcardio201676"],"URL":"https:\/\/doi.org\/10.1038\/nrcardio.2016.76","relation":{},"ISSN":["1759-5002","1759-5010"],"issn-type":[{"value":"1759-5002","type":"print"},{"value":"1759-5010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,19]]},"assertion":[{"value":"19 May 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}